'id','source','accession','title','description','pmid','pub_title','pub_date','pub_author','tech_acc','tech_name','sample_acc','species','exp_type'
1,'GEO',"['GSE128908', 'SRP191461']",'Abnormalities of cellular polarity underlie the primary substrate in a genetic form of atrial fibrillation',"'Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with heart failure and stroke. The primary substrate for AF is poorly understood due to limited access to primary human tissue and the lack of mechanistically faithful in vitro or in vivo models. We used an MYH6:mCherry knock-in reporter line to generate and purify human pluripotent stem cell-derived cardiomyocytes displaying electrophysiological and molecular characteristics of atrial cells (hPSC-atrial cells). We modeled human MYL4 mutants, one of the few definitive genetic causes of AF. Single cell transcriptomics on hPSC-atrial cells (WT and MYL4 mutant) was performed to study changes in gene expression among the cell types that exist in atrial lineage.'",[],[],[],[],['GPL18573'],['Illumina NextSeq 500 (Homo sapiens)'],"[('GSM3688218', 'SRX5654571'), ('GSM3688217', 'SRX5654570')]",['Homo sapiens'],['Expression profiling by high throughput sequencing']
2,'GEO',['GSE133347'],u'Distinct Expression Profiles of long non-coding RNAs and messenger RNAs in circulating leukocytes of Parkinson\u2019s disease',"""The molecular mechanism underlying Parkinson's disease (PD), an increasingly common neurodegenerative disease, remains unclear. Long non-coding RNA (lncRNA) plays essential roles in gene expression and human disease. We hypothesize that lncRNAs are involved in the pathogenesis of PD. We profiled the expression of lncRNA in circulating leukocytes of 5 PD patients and 5 healthy controls using microarray.""",[],[],[],[],['GPL21047'],['Agilent-074348 Human LncRNA v6 4X180K [Probe Name Version]'],"['GSM3906074', 'GSM3906071', 'GSM3906077', 'GSM3906069', 'GSM3906078', 'GSM3906075', 'GSM3906072', 'GSM3906073', 'GSM3906070', 'GSM3906076']",['Homo sapiens'],"['Expression profiling by array', 'Non-coding RNA profiling by array']"
3,'GEO',"['GSE140275', 'SRP229618']",'Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population',"'Background: Long noncoding RNAs (lncRNAs) have been confirmed to be associated with ischemic stroke (IS); however, their involvement still needs to be extensively explored. Therefore, we aimed to study the expression profile of lncRNAs and the potential roles and mechanisms of lncRNAs in the pathogenesis of acute ischemic stroke (AIS) in the Southern Chinese Han population. Methods: lncRNA and mRNA expression profiles in AIS were analyzed using high-throughput RNA sequencing (RNA-Seq) and validated using quantitative real-time polymerase chain reaction (qRT-PCR). Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment and network analyses were performed to predict the functions and interactions of the aberrantly expressed genes. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic value of lncRNAs in AIS. Results: RNA-Seq analysis showed that 428 lncRNAs and 957 mRNAs were significantly upregulated, while 791 lncRNAs and 4263 mRNAs were downregulated in patients with AIS when compared with healthy controls. GO enrichment and KEGG pathway analyses of differentially expressed genes showed that the apoptosis, inflammatory, oxidative and calcium signaling pathways were potentially implicated in AIS pathology. The PCR results showed that the selected lncRNA-C14orf64 and lncRNA-AC136007.2 were significantly downregulated in AIS. ROC curve analysis showed that the area under the ROC curve (AUC) values of lncRNA-C14orf64 and lncRNA-AC136007.2 between AIS and healthy controls were 0.74 and 0.94, respectively. Conclusion: This study provides evidence of altered expression of lncRNAs and their potential functions in AIS. Our findings may facilitate pathological mechanistic studies of lncRNAs in AIS and provide potential diagnostic biomarkers and therapeutic targets for AIS.'",[31849604],['Expression Profile and Potential Functions of Circulating Long Noncoding RNAs in Acute Ischemic Stroke in the Southern Chinese Han Population.'],['2019'],"[['Li S', 'Zheng H', 'Chen L', 'Xu C', 'Qu X', 'Qin Z', 'Gao J', 'Li J', 'Liu J']]",['GPL16791'],['Illumina HiSeq 2500 (Homo sapiens)'],"[('GSM4158685', 'SRX7131021'), ('GSM4158688', 'SRX7131024'), ('GSM4158686', 'SRX7131022'), ('GSM4158689', 'SRX7131025'), ('GSM4158690', 'SRX7131026'), ('GSM4158687', 'SRX7131023')]",['Homo sapiens'],['Expression profiling by high throughput sequencing']
4,'GEO',"['GSE127478', 'SRP187084']",u'Mitochondrial 3243A\u2009>\u2009G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells',"'We obtained three independent sets of endothelial cells differentiated from iPSCs derived from a Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) patient as well as iPSCs that has been corrected for the mitochondrial mutation.'",[31641105],[u'Mitochondrial 3243A\u2009&gt;\u2009G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells.'],['2019 Oct 22'],"[['Pek NMQ', 'Phua QH', 'Ho BX', 'Pang JKS', 'Hor JH', 'An O', 'Yang HH', 'Yu Y', 'Fan Y', 'Ng SY', 'Soh BS']]",['GPL20301'],['Illumina HiSeq 4000 (Homo sapiens)'],"[('GSM3635396', 'SRX5444284'), ('GSM3635393', 'SRX5444281'), ('GSM3635392', 'SRX5444280'), ('GSM3635395', 'SRX5444283'), ('GSM3635394', 'SRX5444282'), ('GSM3635391', 'SRX5444279')]",['Homo sapiens'],['Expression profiling by high throughput sequencing']
5,'GEO',['GSE124026'],'Expression data from stroke patients blood samples',"'Ischemic stroke can be classified depending on its etiology as cardioembolic (CE), large-vessel atheroesclerotic (LAA), lacunar, other or cryptogenic. Our aim was to identify gene expression changes that could differentiate CE and LAA stroke in order to guide the optimal secondary treatment .'",[],[],[],[],['GPL5175'],['[HuEx-1_0-st] Affymetrix Human Exon 1.0 ST Array [transcript (gene) version]'],"['GSM3518972', 'GSM3518978', 'GSM3518975', 'GSM3518974', 'GSM3518971', 'GSM3518977', 'GSM3518980', 'GSM3518979', 'GSM3518976', 'GSM3518981', 'GSM3518973']",['Homo sapiens'],['Expression profiling by array']
6,'GEO',"['GSE129935', 'SRP192825']",'RNA sequencing human monocytes',"'Aim: To improve risk stratification in patients with stable coronary artery disease (CAD), we aimed to identify genes in monocytes predictive of new ischemic events in patients with CAD and determine to what extent expression of these transcripts resembles expression in acute myocardial infarction (AMI). Results: COX10 and ZNF484 distinguished between AMI and the whole group of stable CAD patients with an accuracy of 90%. COX10 and ZNF484 together with MT-COI and WNK1 distinguished AMI patients from stable CAD patients with and without a new event with a sensitivity of 89% and a specificity of 98%. MT-COI and COX10 increased the accuracy for separating stable CAD patients with and without a new coronary event from 68 to 80% in addition to age, gender, BMI, diabetes, lipids, blood pressure and hs-CRP. Interestingly, expression of MT-COI, COX10 and WNK1 (but not ZNF484) in PBMCs paired with that in monocytes; COX10 in whole blood was similar to that in monocytes. Conclusions: This work showed that COX10 and ZNF484, eventually combined with MT-COI and WNK1 have the potential to accurately discriminate between AMI and stable CAD patients, and may improve the risk assessment of stable CAD patients.'",[31821324],"['RNA-sequencing reveals that STRN, ZNF484 and WNK1 add to the value of mitochondrial MT-COI and COX10 as markers of unstable coronary artery disease.']",['2019'],"[['Holvoet P', 'Klocke B', 'Vanhaverbeke M', 'Menten R', 'Sinnaeve P', 'Raitoharju E', u'Lehtim\xe4ki T', 'Oksala N', 'Zinser C', 'Janssens S', 'Sipido K', 'Lyytikainen LP', 'Cagnin S']]",['GPL18573'],['Illumina NextSeq 500 (Homo sapiens)'],"[('GSM3728336', 'SRX5702704'), ('GSM3728313', 'SRX5702681'), ('GSM3728316', 'SRX5702684'), ('GSM3728339', 'SRX5702707'), ('GSM3728333', 'SRX5702701'), ('GSM3728319', 'SRX5702687'), ('GSM3728322', 'SRX5702690'), ('GSM3728345', 'SRX5702713'), ('GSM3728325', 'SRX5702693'), ('GSM3728331', 'SRX5702699'), ('GSM3728342', 'SRX5702710'), ('GSM3728334', 'SRX5702702'), ('GSM3728328', 'SRX5702696'), ('GSM3728314', 'SRX5702682'), ('GSM3728340', 'SRX5702708'), ('GSM3728317', 'SRX5702685'), ('GSM3728337', 'SRX5702705'), ('GSM3728343', 'SRX5702711'), ('GSM3728320', 'SRX5702688'), ('GSM3728346', 'SRX5702714'), ('GSM3728323', 'SRX5702691'), ('GSM3728326', 'SRX5702694'), ('GSM3728329', 'SRX5702697'), ('GSM3728312', 'SRX5702680'), ('GSM3728335', 'SRX5702703'), ('GSM3728315', 'SRX5702683'), ('GSM3728338', 'SRX5702706'), ('GSM3728318', 'SRX5702686'), ('GSM3728341', 'SRX5702709'), ('GSM3728332', 'SRX5702700'), ('GSM3728344', 'SRX5702712'), ('GSM3728321', 'SRX5702689'), ('GSM3728324', 'SRX5702692'), ('GSM3728347', 'SRX5702715'), ('GSM3728327', 'SRX5702695'), ('GSM3728330', 'SRX5702698')]",['Homo sapiens'],['Expression profiling by high throughput sequencing']
7,'GEO',"['GSE120521', 'SRP162681']",'RNA-seq of stable and unstable section of human atherosclerotic plaques',"'Atherosclerosis is a serious and very common condition where plaque builds up inside arteries and that can lead to heart attack or stroke. The development and rupture of the plaque is a complex process, involving the interplay of many cell types and the extracellular environment. We performed RNAseq on stable and unstable regions dissected from fresh human carotid plaques obtained at carotid endarterectomy in symptomatic patients. The dissection of the plaques into stable and unstable regions was based on macroscopic appearance, with unstable regions characterised as the visible zone of plaque rupture.'",[31339449],['The Human-Specific and Smooth Muscle Cell-Enriched LncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling.'],['2019 Aug 16'],"[['Mahmoud AD', 'Ballantyne MD', 'Miscianinov V', 'Pinel K', 'Hung J', 'Scanlon JP', 'Iyinikkel J', 'Kaczynski J', 'Tavares AS', 'Bradshaw AC', 'Mills NL', 'Newby DE', 'Caporali A', 'Gould GW', 'George SJ', 'Ulitsky I', 'Sluimer JC', 'Rodor J', 'Baker AH']]",['GPL16791'],['Illumina HiSeq 2500 (Homo sapiens)'],"[('GSM3402507', 'SRX4741777'), ('GSM3402504', 'SRX4741774'), ('GSM3402506', 'SRX4741776'), ('GSM3402508', 'SRX4741778'), ('GSM3402509', 'SRX4741779'), ('GSM3402505', 'SRX4741775'), ('GSM3402511', 'SRX4741781'), ('GSM3402510', 'SRX4741780')]",['Homo sapiens'],['Expression profiling by high throughput sequencing']
8,'GEO',['GSE104053'],'AGO CLIP reveals an activated network for acute regulation of brain glutamate homeostasis in ischemic stroke','This SuperSeries is composed of the SubSeries listed below.',[],[],[],[],"['GPL15520', 'GPL17021', 'GPL16417']","['Illumina MiSeq (Homo sapiens)', 'Illumina HiSeq 2500 (Mus musculus)', 'Illumina MiSeq (Mus musculus)']","[('GSM2788083', 'SRX3200402'), ('GSM2788060', 'SRX3200379'), ('GSM2788332', 'SRX3200840'), ('GSM2788037', 'SRX3200356'), ('GSM2788014', 'SRX3200342'), ('GSM2788034', 'SRX3200353'), ('GSM2788020', 'SRX3200348'), ('GSM2788057', 'SRX3200376'), ('GSM2788080', 'SRX3200399'), ('GSM2788329', 'SRX3200837'), ('GSM2788326', 'SRX3200873'), ('GSM2788017', 'SRX3200345'), ('GSM2788040', 'SRX3200359'), ('GSM2788077', 'SRX3200396'), ('GSM2788023', 'SRX3200351'), ('GSM2788046', 'SRX3200365'), ('GSM2788069', 'SRX3200388'), ('GSM2788278', 'SRX3200419'), ('GSM2788066', 'SRX3200385'), ('GSM2788043', 'SRX3200362'), ('GSM2788049', 'SRX3200368'), ('GSM2788275', 'SRX3200416'), ('GSM2788315', 'SRX3200862'), ('GSM2788086', 'SRX3200405'), ('GSM2788063', 'SRX3200382'), ('GSM2788318', 'SRX3200865'), ('GSM2788272', 'SRX3200413'), ('GSM2788075', 'SRX3200394'), ('GSM2788052', 'SRX3200371'), ('GSM2788072', 'SRX3200391'), ('GSM2788015', 'SRX3200343'), ('GSM2788078', 'SRX3200397'), ('GSM2788324', 'SRX3200871'), ('GSM2788055', 'SRX3200374'), ('GSM2788281', 'SRX3200422'), ('GSM2788035', 'SRX3200354'), ('GSM2788012', 'SRX3200340'), ('GSM2788321', 'SRX3200868'), ('GSM2788327', 'SRX3200835'), ('GSM2788273', 'SRX3200414'), ('GSM2788084', 'SRX3200403'), ('GSM2788081', 'SRX3200400'), ('GSM2788021', 'SRX3200349'), ('GSM2788061', 'SRX3200380'), ('GSM2788038', 'SRX3200357'), ('GSM2788319', 'SRX3200866'), ('GSM2788058', 'SRX3200377'), ('GSM2788064', 'SRX3200383'), ('GSM2788024', 'SRX3200352'), ('GSM2788330', 'SRX3200838'), ('GSM2788044', 'SRX3200363'), ('GSM2788041', 'SRX3200360'), ('GSM2788018', 'SRX3200346'), ('GSM2788047', 'SRX3200366'), ('GSM2788070', 'SRX3200389'), ('GSM2788316', 'SRX3200863'), ('GSM2788050', 'SRX3200369'), ('GSM2788322', 'SRX3200869'), ('GSM2788079', 'SRX3200398'), ('GSM2788056', 'SRX3200375'), ('GSM2788039', 'SRX3200358'), ('GSM2788325', 'SRX3200872'), ('GSM2788067', 'SRX3200386'), ('GSM2788087', 'SRX3200406'), ('GSM2788279', 'SRX3200420'), ('GSM2788276', 'SRX3200417'), ('GSM2788328', 'SRX3200836'), ('GSM2788053', 'SRX3200372'), ('GSM2788036', 'SRX3200355'), ('GSM2788282', 'SRX3200423'), ('GSM2788059', 'SRX3200378'), ('GSM2788065', 'SRX3200384'), ('GSM2788274', 'SRX3200415'), ('GSM2788085', 'SRX3200404'), ('GSM2788062', 'SRX3200381'), ('GSM2788016', 'SRX3200344'), ('GSM2788076', 'SRX3200395'), ('GSM2788013', 'SRX3200341'), ('GSM2788019', 'SRX3200347'), ('GSM2788073', 'SRX3200392'), ('GSM2788042', 'SRX3200361'), ('GSM2788082', 'SRX3200401'), ('GSM2788323', 'SRX3200870'), ('GSM2788277', 'SRX3200418'), ('GSM2788320', 'SRX3200867'), ('GSM2788071', 'SRX3200390'), ('GSM2788280', 'SRX3200421'), ('GSM2788068', 'SRX3200387'), ('GSM2788317', 'SRX3200864'), ('GSM2788331', 'SRX3200839'), ('GSM2788045', 'SRX3200364'), ('GSM2788022', 'SRX3200350'), ('GSM2788051', 'SRX3200370'), ('GSM2788074', 'SRX3200393'), ('GSM2788048', 'SRX3200367'), ('GSM2788054', 'SRX3200373')]","['Homo sapiens', 'Mus musculus']","['Expression profiling by high throughput sequencing', 'Third-party reanalysis', 'Non-coding RNA profiling by high throughput sequencing']"
9,'GEO',"['GSE104048', 'SRP118313']",'AGO CLIP reveals an activated network for acute regulation of brain glutamate homeostasis in ischemic stroke [dataset 6]',u'Human motor cortex (brodmann\u2019s area 9) tissues analyzed by Argonaute HITS-CLIP to determine human transcriptome-wide AGO binding pattern.',[],[],[],[],['GPL15520'],['Illumina MiSeq (Homo sapiens)'],"[('GSM2788329', 'SRX3200837'), ('GSM2788332', 'SRX3200840'), ('GSM2788327', 'SRX3200835'), ('GSM2788330', 'SRX3200838'), ('GSM2788328', 'SRX3200836'), ('GSM2788331', 'SRX3200839')]",['Homo sapiens'],['Expression profiling by high throughput sequencing']
10,'GEO',['GSE125771'],'RNA expression data from calcified human carotid atherosclerotic plaques',"'Although unstable atherosclerosis in the carotid bifurcation is a significant etiology behind ischemic stroke, clinical imaging methods to distinguish stable from vulnerable lesions are lacking and selection of patients for stroke-preventive intervention still relies on surrogate variables with moderate predictive power, such as the degree of luminal narrowing. Here we combined clinical and diagnostic imaging information by comuted tomography to select patients with calcified plaques for large scale molecular analysis, in an effort to increase our understanding of the pathophysiology behind carotid plaque instability as related to patient- and plaque- phenotype.'",[31109707],['Correlation of computed tomography with carotid plaque transcriptomes associates calcification with lesion-stabilization.'],['2019 Sep'],"[[u'Karl\xf6f E', 'Seime T', 'Dias N', 'Lengquist M', 'Witasp A', 'Almqvist H', 'Kronqvist M', u'G\xe5din JR', 'Odeberg J', 'Maegdefessel L', 'Stenvinkel P', 'Matic LP', 'Hedin U']]",['GPL17586'],['[HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version]'],"['GSM3581731', 'GSM3581708', 'GSM3581728', 'GSM3581714', 'GSM3581711', 'GSM3581734', 'GSM3581717', 'GSM3581740', 'GSM3581737', 'GSM3581743', 'GSM3581720', 'GSM3581736', 'GSM3581716', 'GSM3581713', 'GSM3581733', 'GSM3581719', 'GSM3581739', 'GSM3581745', 'GSM3581722', 'GSM3581742', 'GSM3581721', 'GSM3581725', 'GSM3581718', 'GSM3581744', 'GSM3581724', 'GSM3581730', 'GSM3581741', 'GSM3581727', 'GSM3581707', 'GSM3581738', 'GSM3581710', 'GSM3581726', 'GSM3581709', 'GSM3581723', 'GSM3581706', 'GSM3581729', 'GSM3581715', 'GSM3581735', 'GSM3581712', 'GSM3581732']",['Homo sapiens'],['Expression profiling by array']
11,'GEO',['GSE129091'],'Quantitative variation in m.3243A>G mutation produce discrete changes in energy metabolism',"'Mitochondrial DNA (mtDNA) 3243A>G tRNALeu(UUR) heteroplasmic mutation (m.3243A>G) exhibits clinically heterogeneous phenotypes. While the high mtDNA heteroplasmy exceeding a critical threshold causes mitochondrial encephalomyopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome, the low mtDNA heteroplasmy causes maternally inherited diabetes with or without deafness (MIDD) syndrome. How quantitative differences in mtDNA heteroplasmy produces distinct pathological states has remained elusive. Here we show that despite striking similarities in the energy metabolic gene expression signature, the mitochondrial bioenergetics, biogenesis and fuel catabolic functions are distinct in cells harboring low or high levels of the m.3243A>G mutation compared to wild type cells. We further demonstrate that the low heteroplasmic mutant cells exhibit a coordinate induction of transcriptional regulators of the mitochondrial biogenesis, glucose and fatty acid metabolism pathways that lack in near homoplasmic mutant cells compared to wild type cells. Altogether, these results shed new biological insights on the potential mechanisms by which low mtDNA heteroplasmy may progressively cause diabetes mellitus.'",[30962477],[u'Quantitative Variation in m.3243A\u2009&gt;\u2009G Mutation Produce Discrete Changes in Energy Metabolism.'],['2019 Apr 8'],"[['McMillan RP', 'Stewart S', 'Budnick JA', 'Caswell CC', 'Hulver MW', 'Mukherjee K', 'Srivastava S']]",['GPL570'],['[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array'],"['GSM3693135', 'GSM3693138', 'GSM3693141', 'GSM3693144', 'GSM3693136', 'GSM3693139', 'GSM3693142', 'GSM3693145', 'GSM3693137', 'GSM3693140', 'GSM3693143', 'GSM3693146']",['Homo sapiens'],['Expression profiling by array']
12,'GEO',['GSE129409'],"'The integrative regulatory network of circRNA, microRNA and mRNA in atrial fibrillation'","u'Atrial fibrillation (AF) is the most common irregular heart rhythm which influence approximately 1\u20132% of the general population. As a potential factor for ischemic stroke, AF could also cause heart failure. The mechanisms behind AF pathogenesis are complex and remains elusive. As a new category of non-coding RNAs (ncRNAs), circular RNAs (circRNAs) have been known as the key of developmental processes, regulation of cell function, pathogenesis of heart diseases and pathological responses which could provide novel sight into the pathogenesis of AF. circRNAs function as modulators of microRNAs in cardiac disease. To investigate the regulatory mechanism of circRNA in atrial fibrillation, especially the complex interactions among circRNA, microRNA and mRNA, we collected the heart tissues from three AF patients and three healthy controls and profiled their circRNA expressions with circRNA Microarray. The differentially expressed circRNAs were identified and the biological functions of their interaction microRNAs and mRNAs were analyzed. Our results provided novel insights of the circRNA roles in atrial fibrillation and proposed highly possible interaction mechanisms among circRNAs, microRNAs and mRNAs.'",[31249590],"['The Integrative Regulatory Network of circRNA, microRNA, and mRNA in Atrial Fibrillation.']",['2019'],"[['Jiang S', 'Guo C', 'Zhang W', 'Che W', 'Zhang J', 'Zhuang S', 'Wang Y', 'Zhang Y', 'Liu B']]",['GPL21825'],['074301 Arraystar Human CircRNA microarray V2'],"['GSM3712568', 'GSM3712566', 'GSM3712569', 'GSM3712570', 'GSM3712567', 'GSM3712565']",['Homo sapiens'],"['Expression profiling by array', 'Non-coding RNA profiling by array']"
13,'GEO',['GSE112882'],'Cerebral Cavernous Malformation Proteins and MEKK3 Coordinately Modulate SMURF1 Abundance to Control RhoA-dependent Endothelial Cell Phenotypic State',"'Cerebral Cavernous Malformations (CCM), caused by loss of CCM1, CCM2 or CCM3 in endothelial cells (ECs), are leaky capillaries causing seizures and stroke. CCM protein loss gives overlapping changes in biomechanical and transcriptional properties of ECs, due to common RhoA-driven alterations in cytoskeletal organization and intracellular signaling. However, EC models of 3-D tube formation show loss of each CCM protein generates distinct morphological defects in tubular structures. Computational modeling, live-cell imaging and RNA sequencing revealed distinct functional roles of CCM1 and CCM3 in regulating EC-EC and EC-matrix interactions. CCM2 has an intermediate phenotype consistent with its interaction with CCM1 and CCM3. In ECs, CCM proteins regulate SMURF1 E3 ligase ubiquitination and degradation of RhoA. Loss of CCM proteins results in loss of SMURF1 and a concomitant increase of MEKK3, a negative regulator of SMURF1 expression. We propose CCM lesions develop because of dysregulated SMURF1 resulting in RhoA and MEKK3 gain-of-function.'",[],[],[],[],['GPL18573'],['Illumina NextSeq 500 (Homo sapiens)'],"['GSM3090406', 'GSM3090426', 'GSM3090403', 'GSM3090423', 'GSM3090420', 'GSM3090417', 'GSM3090414', 'GSM3090401', 'GSM3090421', 'GSM3090418', 'GSM3090429', 'GSM3090415', 'GSM3090412', 'GSM3090409', 'GSM3090416', 'GSM3090410', 'GSM3090424', 'GSM3090413', 'GSM3090407', 'GSM3090427', 'GSM3090404', 'GSM3090411', 'GSM3090408', 'GSM3090405', 'GSM3090428', 'GSM3090425', 'GSM3090402', 'GSM3090422', 'GSM3090419']",['Homo sapiens'],['Expression profiling by high throughput sequencing']
14,'GEO',"['GSE122709', 'SRP169610']",'LncRNA expression profiling of ischemic stroke patients','Our study reveals that ischemic stroke can influence the expression of LncRNAs and mRNAs in the peripheral blood at both the acute and subacute stages',[30774621],['LncRNA Expression Profiling of Ischemic Stroke During the Transition From the Acute to Subacute Stage.'],['2019'],"[['Zhu W', 'Tian L', 'Yue X', 'Liu J', 'Fu Y', 'Yan Y']]",['GPL20795'],['HiSeq X Ten (Homo sapiens)'],"[('GSM3483776', 'SRX5027124'), ('GSM3483773', 'SRX5027121'), ('GSM3483779', 'SRX5027127'), ('GSM3483778', 'SRX5027126'), ('GSM3483767', 'SRX5027115'), ('GSM3483770', 'SRX5027118'), ('GSM3483766', 'SRX5027114'), ('GSM3483772', 'SRX5027120'), ('GSM3483769', 'SRX5027117'), ('GSM3483775', 'SRX5027123'), ('GSM3483771', 'SRX5027119'), ('GSM3483768', 'SRX5027116'), ('GSM3483780', 'SRX5027128'), ('GSM3483777', 'SRX5027125'), ('GSM3483774', 'SRX5027122')]",['Homo sapiens'],"['Expression profiling by high throughput sequencing', 'Non-coding RNA profiling by high throughput sequencing']"
15,'GEO',['GSE109187'],'Gene expression profiling of human brain microvascular pericytes with hypoxia and acidosis stimulation',"u'The objective of the present study is to investigate the effect of a stroke mimic condition on human brain pericytes. Comparative gene expression analysis was performed using cultured human brain microvascular pericytes with 1% oxygen for 24 hours or with acidic condition at pH 6.5 for 24 hours. Gene expression was analyzed using 3D-Gene\xae Human 25k oligonucleotide microarrays and computational gene expression analysis tools. Incubation of cells under these conditions resulted in significant changes in numerous genes related with glycolysis, immune responses, and angiogenesis.'",[],[],[],[],['GPL5639'],['3D-Gene Human Oligo chip 25k'],"['GSM2935068', 'GSM2935071', 'GSM2935069', 'GSM2935070']",['Homo sapiens'],['Expression profiling by array']
16,'GEO',"['GSE124500', 'SRP174896']",'Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells',"u'Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a rare hereditary cerebrovascular disease caused by a NOTCH3 mutation. However, the underlying cellular and molecular mechanisms remain unidentified. Here, we generated non-integrative induced pluripotent stem cells (iPSCs) from fibroblasts from a CADASIL patient harboring a heterozygous NOTCH3 mutation (c.3226C>T, p.R1076C). Vascular smooth muscle cells (VSMCs) differentiated from CADASIL-specific iPSCs showed transcriptional changes and disease-associated cellular dysfunction, including activation of the NF-kB signaling pathway, cytoskeleton disorganization, and excessive cell proliferation. In comparison, these abnormalities were not observed in vascular endothelial cells (VECs) derived from the patient\u2019s iPSCs. Importantly, the abnormal upregulation of NF-kB target genes in CADASIL VSMCs was diminished by a NOTCH pathway inhibitor, providing a potential therapeutic strategy for CADASIL. Overall, using this iPSC-based disease model, our study identified clues for studying the disease mechanisms of CADASIL and developing treatment strategies for this disease.'",[30778920],['Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells.'],['2019 Apr'],"[['Ling C', 'Liu Z', 'Song M', 'Zhang W', 'Wang S', 'Liu X', 'Ma S', 'Sun S', 'Fu L', 'Chu Q', 'Belmonte JCI', 'Wang Z', 'Qu J', 'Yuan Y', 'Liu GH']]",['GPL20795'],['HiSeq X Ten (Homo sapiens)'],"[('GSM3535321', 'SRX5190397'), ('GSM3535324', 'SRX5190400'), ('GSM3535313', 'SRX5190389'), ('GSM3535315', 'SRX5190391'), ('GSM3535318', 'SRX5190394'), ('GSM3535314', 'SRX5190390'), ('GSM3535317', 'SRX5190393'), ('GSM3535320', 'SRX5190396'), ('GSM3535316', 'SRX5190392'), ('GSM3535323', 'SRX5190399'), ('GSM3535319', 'SRX5190395'), ('GSM3535322', 'SRX5190398')]",['Homo sapiens'],['Expression profiling by high throughput sequencing']
17,'GEO',['GSE121868'],'Profiles of Extracellular RNA in Cerebrospinal Fluid and Plasma from Subarachnoid Hemorrhage Patients',"'Brain injury resulting from hemorrhagic stroke is clinically challenging to manage and results in high rates of morbidity and mortality. The pathophysiology of brain damage resulting from aneurysmal subarachnoid hemorrhage (aSAH) is largely unknown, and methods to treat and monitor patients are variable with no meaningful correlations to patient outcome. Prediction of patient risk for serious neurological complications is currently a significant clinical obstacle. An extracellular RNA (exRNA) biomarker to predict onset and severity of brain damage would improve patient outcomes. We sequenced plasma and CSF samples from adult patients with SAH. Samples were collected from post bleed day 1 to day 7. Total exRNA was isolated from each sample. In addition, we prepared a subset of 140 CSF samples, isolating the RNA contained within extracellular vesicles and vesicle-depleted biofluid.'",[],[],[],[],['GPL11154'],['Illumina HiSeq 2000 (Homo sapiens)'],"['GSM3448673', 'GSM3448553', 'GSM3448650', 'GSM3448318', 'GSM3448341', 'GSM3448364', 'GSM3448401', 'GSM3448424', 'GSM3448281', 'GSM3448484', 'GSM3448756', 'GSM3448470', 'GSM3448636', 'GSM3448447', 'GSM3448530', 'GSM3448567', 'GSM3448779', 'GSM3448719', 'GSM3448507', 'GSM3448590', 'GSM3448696', 'GSM3448387', 'GSM3448613', 'GSM3448739', 'GSM3448444', 'GSM3448384', 'GSM3448467', 'GSM3448527', 'GSM3448550', 'GSM3448490', 'GSM3448573', 'GSM3448776', 'GSM3448324', 'GSM3448656', 'GSM3448278', 'GSM3448407', 'GSM3448633', 'GSM3448338', 'GSM3448381', 'GSM3448361', 'GSM3448464', 'GSM3448421', 'GSM3448716', 'GSM3448487', 'GSM3448693', 'GSM3448610', 'GSM3448547', 'GSM3448301', 'GSM3448321', 'GSM3448344', 'GSM3448298', 'GSM3448699', 'GSM3448404', 'GSM3448782', 'GSM3448759', 'GSM3448676', 'GSM3448570', 'GSM3448653', 'GSM3448593', 'GSM3448736', 'GSM3448616', 'GSM3448493', 'GSM3448713', 'GSM3448630', 'GSM3448516', 'GSM3448427', 'GSM3448599', 'GSM3448510', 'GSM3448290', 'GSM3448576', 'GSM3448622', 'GSM3448304', 'GSM3448350', 'GSM3448433', 'GSM3448410', 'GSM3448682', 'GSM3448373', 'GSM3448539', 'GSM3448456', 'GSM3448765', 'GSM3448705', 'GSM3448742', 'GSM3448659', 'GSM3448327', 'GSM3448267', 'GSM3448725', 'GSM3448702', 'GSM3448785', 'GSM3448762', 'GSM3448679', 'GSM3448748', 'GSM3448665', 'GSM3448642', 'GSM3448619', 'GSM3448476', 'GSM3448536', 'GSM3448559', 'GSM3448582', 'GSM3448310', 'GSM3448596', 'GSM3448264', 'GSM3448287', 'GSM3448370', 'GSM3448393', 'GSM3448519', 'GSM3448284', 'GSM3448307', 'GSM3448430', 'GSM3448513', 'GSM3448413', 'GSM3448347', 'GSM3448602', 'GSM3448453', 'GSM3448367', 'GSM3448390', 'GSM3448473', 'GSM3448685', 'GSM3448496', 'GSM3448579', 'GSM3448639', 'GSM3448724', 'GSM3448330', 'GSM3448533', 'GSM3448745', 'GSM3448353', 'GSM3448436', 'GSM3448722', 'GSM3448450', 'GSM3448270', 'GSM3448768', 'GSM3448429', 'GSM3448489', 'GSM3448556', 'GSM3448309', 'GSM3448535', 'GSM3448512', 'GSM3448662', 'GSM3448595', 'GSM3448641', 'GSM3448701', 'GSM3448618', 'GSM3448323', 'GSM3448406', 'GSM3448532', 'GSM3448784', 'GSM3448306', 'GSM3448329', 'GSM3448744', 'GSM3448638', 'GSM3448615', 'GSM3448721', 'GSM3448698', 'GSM3448412', 'GSM3448369', 'GSM3448452', 'GSM3448475', 'GSM3448718', 'GSM3448538', 'GSM3448558', 'GSM3448635', 'GSM3448761', 'GSM3448286', 'GSM3448572', 'GSM3448326', 'GSM3448263', 'GSM3448392', 'GSM3448346', 'GSM3448303', 'GSM3448349', 'GSM3448343', 'GSM3448432', 'GSM3448409', 'GSM3448741', 'GSM3448449', 'GSM3448621', 'GSM3448678', 'GSM3448515', 'GSM3448283', 'GSM3448366', 'GSM3448389', 'GSM3448472', 'GSM3448661', 'GSM3448770', 'GSM3448555', 'GSM3448747', 'GSM3448578', 'GSM3448461', 'GSM3448658', 'GSM3448781', 'GSM3448495', 'GSM3448266', 'GSM3448521', 'GSM3448764', 'GSM3448552', 'GSM3448544', 'GSM3448598', 'GSM3448386', 'GSM3448469', 'GSM3448704', 'GSM3448492', 'GSM3448681', 'GSM3448575', 'GSM3448687', 'GSM3448664', 'GSM3448581', 'GSM3448355', 'GSM3448733', 'GSM3448378', 'GSM3448710', 'GSM3448627', 'GSM3448332', 'GSM3448415', 'GSM3448604', 'GSM3448438', 'GSM3448352', 'GSM3448458', 'GSM3448670', 'GSM3448624', 'GSM3448564', 'GSM3448275', 'GSM3448358', 'GSM3448561', 'GSM3448435', 'GSM3448750', 'GSM3448518', 'GSM3448753', 'GSM3448541', 'GSM3448667', 'GSM3448730', 'GSM3448272', 'GSM3448644', 'GSM3448647', 'GSM3448335', 'GSM3448295', 'GSM3448455', 'GSM3448441', 'GSM3448727', 'GSM3448773', 'GSM3448498', 'GSM3448269', 'GSM3448504', 'GSM3448684', 'GSM3448587', 'GSM3448292', 'GSM3448375', 'GSM3448398', 'GSM3448481', 'GSM3448767', 'GSM3448474', 'GSM3448478', 'GSM3448584', 'GSM3448580', 'GSM3448686', 'GSM3448271', 'GSM3448315', 'GSM3448354', 'GSM3448601', 'GSM3448557', 'GSM3448372', 'GSM3448707', 'GSM3448395', 'GSM3448268', 'GSM3448291', 'GSM3448374', 'GSM3448746', 'GSM3448418', 'GSM3448501', 'GSM3448663', 'GSM3448640', 'GSM3448524', 'GSM3448690', 'GSM3448607', 'GSM3448351', 'GSM3448289', 'GSM3448312', 'GSM3448683', 'GSM3448397', 'GSM3448766', 'GSM3448583', 'GSM3448457', 'GSM3448480', 'GSM3448288', 'GSM3448563', 'GSM3448371', 'GSM3448394', 'GSM3448477', 'GSM3448500', 'GSM3448772', 'GSM3448454', 'GSM3448414', 'GSM3448666', 'GSM3448560', 'GSM3448497', 'GSM3448520', 'GSM3448437', 'GSM3448603', 'GSM3448626', 'GSM3448543', 'GSM3448308', 'GSM3448723', 'GSM3448391', 'GSM3448265', 'GSM3448769', 'GSM3448331', 'GSM3448494', 'GSM3448314', 'GSM3448328', 'GSM3448411', 'GSM3448434', 'GSM3448517', 'GSM3448729', 'GSM3448706', 'GSM3448623', 'GSM3448600', 'GSM3448294', 'GSM3448646', 'GSM3448703', 'GSM3448400', 'GSM3448377', 'GSM3448460', 'GSM3448540', 'GSM3448483', 'GSM3448311', 'GSM3448417', 'GSM3448620', 'GSM3448537', 'GSM3448749', 'GSM3448334', 'GSM3448609', 'GSM3448726', 'GSM3448643', 'GSM3448669', 'GSM3448709', 'GSM3448503', 'GSM3448715', 'GSM3448320', 'GSM3448277', 'GSM3448300', 'GSM3448586', 'GSM3448775', 'GSM3448383', 'GSM3448692', 'GSM3448606', 'GSM3448403', 'GSM3448380', 'GSM3448426', 'GSM3448509', 'GSM3448486', 'GSM3448592', 'GSM3448712', 'GSM3448689', 'GSM3448274', 'GSM3448297', 'GSM3448695', 'GSM3448566', 'GSM3448589', 'GSM3448612', 'GSM3448317', 'GSM3448506', 'GSM3448529', 'GSM3448340', 'GSM3448423', 'GSM3448396', 'GSM3448313', 'GSM3448336', 'GSM3448502', 'GSM3448419', 'GSM3448714', 'GSM3448631', 'GSM3448608', 'GSM3448280', 'GSM3448363', 'GSM3448525', 'GSM3448728', 'GSM3448337', 'GSM3448420', 'GSM3448442', 'GSM3448738', 'GSM3448443', 'GSM3448655', 'GSM3448548', 'GSM3448526', 'GSM3448632', 'GSM3448549', 'GSM3448523', 'GSM3448735', 'GSM3448499', 'GSM3448333', 'GSM3448319', 'GSM3448629', 'GSM3448416', 'GSM3448439', 'GSM3448734', 'GSM3448522', 'GSM3448711', 'GSM3448651', 'GSM3448605', 'GSM3448545', 'GSM3448628', 'GSM3448360', 'GSM3448466', 'GSM3448752', 'GSM3448463', 'GSM3448546', 'GSM3448569', 'GSM3448732', 'GSM3448652', 'GSM3448446', 'GSM3448357', 'GSM3448440', 'GSM3448758', 'GSM3448675', 'GSM3448778', 'GSM3448755', 'GSM3448672', 'GSM3448649', 'GSM3448339', 'GSM3448399', 'GSM3448422', 'GSM3448359', 'GSM3448505', 'GSM3448731', 'GSM3448276', 'GSM3448479', 'GSM3448708', 'GSM3448562', 'GSM3448293', 'GSM3448625', 'GSM3448316', 'GSM3448774', 'GSM3448751', 'GSM3448668', 'GSM3448645', 'GSM3448465', 'GSM3448691', 'GSM3448568', 'GSM3448585', 'GSM3448654', 'GSM3448356', 'GSM3448688', 'GSM3448462', 'GSM3448322', 'GSM3448345', 'GSM3448273', 'GSM3448428', 'GSM3448451', 'GSM3448534', 'GSM3448737', 'GSM3448296', 'GSM3448379', 'GSM3448368', 'GSM3448760', 'GSM3448402', 'GSM3448531', 'GSM3448771', 'GSM3448365', 'GSM3448448', 'GSM3448485', 'GSM3448471', 'GSM3448637', 'GSM3448554', 'GSM3448425', 'GSM3448577', 'GSM3448757', 'GSM3448342', 'GSM3448743', 'GSM3448777', 'GSM3448660', 'GSM3448754', 'GSM3448763', 'GSM3448694', 'GSM3448740', 'GSM3448680', 'GSM3448657', 'GSM3448634', 'GSM3448551', 'GSM3448574', 'GSM3448445', 'GSM3448482', 'GSM3448588', 'GSM3448459', 'GSM3448542', 'GSM3448565', 'GSM3448671', 'GSM3448376', 'GSM3448648', 'GSM3448528', 'GSM3448325', 'GSM3448348', 'GSM3448611', 'GSM3448299', 'GSM3448405', 'GSM3448382', 'GSM3448511', 'GSM3448617', 'GSM3448305', 'GSM3448285', 'GSM3448783', 'GSM3448508', 'GSM3448488', 'GSM3448591', 'GSM3448700', 'GSM3448571', 'GSM3448677', 'GSM3448594', 'GSM3448720', 'GSM3448388', 'GSM3448697', 'GSM3448614', 'GSM3448780', 'GSM3448674', 'GSM3448282', 'GSM3448717', 'GSM3448431', 'GSM3448514', 'GSM3448491', 'GSM3448597', 'GSM3448302', 'GSM3448408', 'GSM3448279', 'GSM3448362', 'GSM3448385', 'GSM3448468']",['Homo sapiens'],"['Expression profiling by high throughput sequencing', 'Non-coding RNA profiling by high throughput sequencing']"
18,'GEO',"['GSE88888', 'SRP091714']",u'A monocyte gene expression signature in the early clinical course of Parkinson\u2019s disease',"u'Recent studies suggest that the activation of the innate immune system is an integral part of Parkinson\u2019s disease (PD) pathology. Monocytes have a critical role as effectors and regulators of the innate immune system, and a recent expression quantitative trait locus (eQTL) study links monocytes to PD. Patients diagnosed with PD according to the National Institute of Neurological Disorders and Stroke diagnostic criteria for PD were included. We applied a standardized procedure with blood drawing from fasting participants. PD patients with Hoehn and Yahr > 2 and/or cognitive impairment were not recruited. Participants with a history of cancer, infectious diseases within the past three months, or taking anti-inflammatory drugs were excluded. Altogether, we analyzed the monocytic transcriptome profiles of 10 PD patients and 9 age- and sex-matched controls using mRNA sequencing.'",[30018301],"[""A monocyte gene expression signature in the early clinical course of Parkinson's disease.""]",['2018 Jul 17'],"[['Schlachetzki JCM', 'Prots I', 'Tao J', 'Chun HB', 'Saijo K', 'Gosselin D', 'Winner B', 'Glass CK', 'Winkler J']]",['GPL11154'],['Illumina HiSeq 2000 (Homo sapiens)'],"[('GSM2350784', 'SRX2250661'), ('GSM3501959', 'SRX5096296'), ('GSM2350781', 'SRX2250658'), ('GSM2350787', 'SRX2250664'), ('GSM2350793', 'SRX2250670'), ('GSM2350790', 'SRX2250667'), ('GSM2350786', 'SRX2250663'), ('GSM2350789', 'SRX2250666'), ('GSM2350792', 'SRX2250669'), ('GSM2350795', 'SRX2250672'), ('GSM2350791', 'SRX2250668'), ('GSM2350794', 'SRX2250671'), ('GSM2350797', 'SRX2250674'), ('GSM2350783', 'SRX2250660'), ('GSM3501958', 'SRX5096295'), ('GSM2350780', 'SRX2250657'), ('GSM2350779', 'SRX2250656'), ('GSM2350796', 'SRX2250673'), ('GSM2350788', 'SRX2250665'), ('GSM3501957', 'SRX5096294')]",['Homo sapiens'],['Expression profiling by high throughput sequencing']
19,'GEO',['GSE114897'],'Real-time quantitative PCR analysis of human stroke patients recovering from upper extremity hemiparesis',"'Fasting blood samples were collected from 27 stroke patients in EDTA tubes mean 19 days post-stroke, plasma was extracted and frozen at -80C, then 200uL of plasma sent for qPCR.'",[30135469],['Plasma microRNA markers of upper limb recovery following human stroke.'],['2018 Aug 22'],"[['Edwardson MA', 'Zhong X', 'Fiandaca MS', 'Federoff HJ', 'Cheema AK', 'Dromerick AW']]",['GPL18942'],['Applied Biosystems Taqman Low Density Array Human microRNA Card A+B Set v3.0'],"['GSM3154169', 'GSM3154172', 'GSM3154166', 'GSM3154186', 'GSM3154163', 'GSM3154180', 'GSM3154183', 'GSM3154160', 'GSM3154164', 'GSM3154167', 'GSM3154161', 'GSM3154181', 'GSM3154184', 'GSM3154178', 'GSM3154175', 'GSM3154176', 'GSM3154182', 'GSM3154162', 'GSM3154173', 'GSM3154179', 'GSM3154170', 'GSM3154177', 'GSM3154171', 'GSM3154174', 'GSM3154168', 'GSM3154185', 'GSM3154165']",['Homo sapiens'],['Expression profiling by RT-PCR']
20,'GEO',['GSE102106'],"'Gene Expression of Primary Human Type I Alveolar Epithelial Cells Exposed to Bacillus anthracis, Sterne endospores'","u'The lung is the entry site for Bacillus anthracis in inhalation anthrax, the most deadly form of the disease. Spores must escape through the alveolar epithelial cell (AEC) barrier and migrate to regional lymph nodes, germinate and enter the circulatory system to cause disease. Several mechanisms to explain alveolar escape have been postulated, and all these tacitly involve the AEC barrier. In this study, we incorporate our primary human type I AEC model, microarray gene profiling and gene enrichment analysis to study the response of AEC to B. anthracis, (Sterne) spores at 4 and 24 hours post-exposure. Spore exposure altered gene expression in AEC after 4 and 24 hours and differentially expressed genes (\xb11.3 fold, p \u2264 0.05) included CCL4/MIP-1\u03b2 (4 hours), CXCL8/IL-8 (4 and 24 hours) and CXCL5/ENA-78 (24 hours). Gene enrichment analysis revealed that pathways involving cytokine or chemokine activity, receptor binding, and innate immune responses to infection were prominent. Microarray results were confirmed by qRT-PCR and multiplex ELISA assays. Chemotaxis assays demonstrated that spores induced the release of biologically active neutrophil and monocyte chemokines, and that CXCL8/IL-8 was the major neutrophil chemokine. The small or sub-chemotactic doses of CXCL5/ENA-78, CXCL3/GRO\u03b2\u03b2 and CCL20/MIP-3\u03b1 may contribute to chemotaxis by priming effects. These data provide the first whole transcriptomic description of the human type I AEC initial response to B. anthracis spore exposure, and contribute to an increased understanding of the role of AEC in the pathogenesis of inhalational anthrax. We used microarrays to create a whole transcriptomic description of the response of primary human type I alveolar epithelial cells to B. anthracis spore exposure and demonstrated that several of the most upregulated differentially expressed genes included those for neutrophil and monocyte chemokines.'",[29704667],['Gene expression profiling of primary human type I alveolar epithelial cells exposed to Bacillus anthracis spores reveals induction of neutrophil and monocyte chemokines.'],['2018 Aug'],"[['Booth JL', 'Duggan ES', 'Patel VI', 'Wu W', 'Burian DM', 'Hutchings DC', 'White VL', 'Coggeshall KM', 'Dozmorov MG', 'Metcalf JP']]",['GPL16686'],['[HuGene-2_0-st] Affymetrix Human Gene 2.0 ST Array [transcript (gene) version]'],"['GSM2723967', 'GSM2723970', 'GSM2723964', 'GSM2723973', 'GSM2723965', 'GSM2723968', 'GSM2723971', 'GSM2723966', 'GSM2723974', 'GSM2723969', 'GSM2723972', 'GSM2723975']",['Homo sapiens'],['Expression profiling by array']
21,'GEO',['GSE113013'],'Comparison of atrial appendage tissues of patients with Valvular Heart Disease and patients with Valvular Heart Disease-Atrial Fibrillation',"'Atrial fibrillation (AF) is the most common heart arrhythmia disease. The greatest risk of atrial fibrillation is stroke, and stroke caused by valvular heart disease with atrial fibrillation (AF-VHD) is more serious. the development mechanism from VHD to AF-VHD is not yet clear. The research on expression profiles of lncRNA and mRNA is helpful to explore molecular mechanism in patients with valvular heart disease who develop atrial fibrillation.'",[],[],[],[],['GPL16956'],['Agilent-045997 Arraystar human lncRNA microarray V3 (Probe Name Version)'],"['GSM3093575', 'GSM3093572', 'GSM3093569', 'GSM3093570', 'GSM3093576', 'GSM3093573', 'GSM3093571', 'GSM3093568', 'GSM3093574', 'GSM3093577']",['Homo sapiens'],"['Expression profiling by array', 'Non-coding RNA profiling by array']"
22,'GEO',['GSE109233'],"'No-glucose, hypoxic or ischemic (ODG) treatment of pericytes'","'Brain pericytes are important to maintain vascular integrity of the neurovascular unit under both, physiological and ischemic conditions. Ischemic stroke is known to induce an inflammatory and hypoxic response due to the lack of oxygen and glucose in the brain tissue. How this early response to ischemia is molecularly regulated in pericytes is largely unknown but may be of importance for future therapeutic targets .Here we evaluate the transcriptional responses in in vitro cultured human brain pericytes after oxygen and/or glucose deprivation. Hypoxia has been widely known to stabilise the transcription factor hypoxia inducible factor 1-alpha (HIF1alpha) and mediate the induction of hypoxic transcriptional programs after ischemia. However, we find that the transcription factors Jun Proto-Oncogene (c-JUN), Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells (NFkappaB) and signal transducer and activator of transcription 3 (STAT3) bind genes regulated after 2 hours of omitted glucose and oxygen before HIF1alpha. Potent HIF1alpha responses require 6 hours of hypoxia to substantiate transcriptional regulation comparable to either c-JUN or STAT3. We show that STAT3 and c-JUN are regulating their bound genes before HIF1alpha after 2 hours of hypoxia or omitted glucose and oxygen, suggesting that HIF1alpha is not the initiating trans-acting factor in the response of pericytes to ischemia.'",[29518129],[u'STAT3 precedes HIF1\u03b1 transcriptional responses to oxygen and oxygen and glucose deprivation in human brain pericytes.'],['2018'],"[['Carlsson R', u'\xd6zen I', 'Barbariga M', 'Gaceb A', 'Roth M', 'Paul G']]",['GPL10558'],['Illumina HumanHT-12 V4.0 expression beadchip'],"['GSM2935659', 'GSM2935682', 'GSM2935679', 'GSM2935662', 'GSM2935673', 'GSM2935656', 'GSM2935676', 'GSM2935657', 'GSM2935674', 'GSM2935680', 'GSM2935677', 'GSM2935665', 'GSM2935671', 'GSM2935669', 'GSM2935668', 'GSM2935675', 'GSM2935672', 'GSM2935660', 'GSM2935666', 'GSM2935663', 'GSM2935670', 'GSM2935664', 'GSM2935667', 'GSM2935655', 'GSM2935678', 'GSM2935661', 'GSM2935658', 'GSM2935681']",['Homo sapiens'],['Expression profiling by array']
23,'GEO',"['GSE106520', 'SRP123611']",'RNA-seq in neutrophils from patients with intracranial aneurysms',"'In this study, we explored transcriptional differences in human neutrophils from patients with intracranial aneurysms and a demographic and comorbidity paired population of controls'","[29342213, 31666072]","['Circulating neutrophil transcriptome may reveal intracranial aneurysm signature.', 'Epigenetic landscapes suggest that genetic risk for intracranial aneurysm operates on the endothelium.']","['2018', '2019 Oct 30']","[['Tutino VM', 'Poppenberg KE', 'Jiang K', 'Jarvis JN', 'Sun Y', 'Sonig A', 'Siddiqui AH', 'Snyder KV', 'Levy EI', 'Kolega J', 'Meng H'], ['Poppenberg KE', 'Jiang K', 'Tso MK', 'Snyder KV', 'Siddiqui AH', 'Kolega J', 'Jarvis JN', 'Meng H', 'Tutino VM']]",['GPL16791'],['Illumina HiSeq 2500 (Homo sapiens)'],"[('GSM2839736', 'SRX3361945'), ('GSM2839739', 'SRX3361948'), ('GSM2839733', 'SRX3361942'), ('GSM2839745', 'SRX3361954'), ('GSM2839722', 'SRX3361931'), ('GSM2839742', 'SRX3361951'), ('GSM2839725', 'SRX3361934'), ('GSM2839751', 'SRX3361960'), ('GSM2839728', 'SRX3361937'), ('GSM2839731', 'SRX3361940'), ('GSM2839734', 'SRX3361943'), ('GSM2839748', 'SRX3361957'), ('GSM2839740', 'SRX3361949'), ('GSM2839737', 'SRX3361946'), ('GSM2839723', 'SRX3361932'), ('GSM2839749', 'SRX3361958'), ('GSM2839726', 'SRX3361935'), ('GSM2839746', 'SRX3361955'), ('GSM2839729', 'SRX3361938'), ('GSM2839743', 'SRX3361952'), ('GSM2839732', 'SRX3361941'), ('GSM2839752', 'SRX3361961'), ('GSM2839735', 'SRX3361944'), ('GSM2839724', 'SRX3361933'), ('GSM2839741', 'SRX3361950'), ('GSM2839727', 'SRX3361936'), ('GSM2839730', 'SRX3361939'), ('GSM2839744', 'SRX3361953'), ('GSM2839721', 'SRX3361930'), ('GSM2839738', 'SRX3361947'), ('GSM2839750', 'SRX3361959'), ('GSM2839747', 'SRX3361956')]",['Homo sapiens'],['Expression profiling by high throughput sequencing']
24,'GEO',['GSE96621'],'Comparison miRNA expression between atherosclerotic and non-atherosclerotic ischemic stroke patients','The difference of circulating miRNA expressions by the presence of atherosclerosis in intra- and extra-cranial vessels were evaluated using serum of ischemic stroke patients.',[28557988],['Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence.'],['2017'],"[['Jeong HS', 'Kim JY', 'Lee SH', 'Hwang J', 'Shin JW', 'Song KS', 'Lee S', 'Kim J']]",['GPL18942'],['Applied Biosystems Taqman Low Density Array Human microRNA Card A+B Set v3.0'],"['GSM2536692', 'GSM2536695', 'GSM2536698', 'GSM2536691', 'GSM2536694', 'GSM2536697', 'GSM2536700', 'GSM2536703', 'GSM2536696', 'GSM2536699', 'GSM2536701', 'GSM2536705', 'GSM2536704', 'GSM2536702', 'GSM2536693']",['Homo sapiens'],['Expression profiling by RT-PCR']
25,'GEO',"['GSE77784', 'SRP069864']",'MOF acetyl transferase regulates transcription and respiration in mitochondria',"'Histone acetylation is sensitive to metabolic cues, however interplay between histone acetyl transferases and cellular metabolism remains poorly understood. Here we report the localization of a classical nuclear HAT- MOF and members of Non-Specific Lethal complex in mitochondria. MOF regulates expression of oxidative phosphorylation (OXPHOS) genes, residing in both nuclear and mitochondrial genomes, selectively in aerobically respiring cells. Furthermore, MOF/KANSL1 depletion causes impaired mitochondrial translation and reduced respiration. MOF loss is catastrophic for tissues with high-energy consumption. In mouse hearts, Mof knockout causes hypertrophic cardiomyopathy, compromised ventricular contractility/ stroke volume and ultimately leads to cardiac failure within three weeks of birth. RNA-seq analysis of the cardiomyocytes revealed deregulation of mitochondrial nutrient metabolism and OXPHOS pathways. Consistently, electron microscopy on affected tissues revealed mitochondrial deterioration with high tissue heterogeneity, commonly observed in mitochondrial diseases. Thus, we reveal a novel function of MOF in mitochondrial homeostasis and propose MOF as a sensor connecting epigenetic regulation to metabolism.'",[27768893],['MOF Acetyl Transferase Regulates Transcription and Respiration in Mitochondria.'],['2016 Oct 20'],"[['Chatterjee A', 'Seyfferth J', 'Lucci J', 'Gilsbach R', 'Preissl S', u'B\xf6ttinger L', u'M\xe5rtensson CU', 'Panhale A', 'Stehle T', 'Kretz O', 'Sahyoun AH', 'Avilov S', 'Eimer S', 'Hein L', 'Pfanner N', 'Becker T', 'Akhtar A']]","['GPL17021', 'GPL16791']","['Illumina HiSeq 2500 (Mus musculus)', 'Illumina HiSeq 2500 (Homo sapiens)']","[('GSM2059223', 'SRX1569993'), ('GSM2059226', 'SRX1569996'), ('GSM2059220', 'SRX1569990'), ('GSM2059217', 'SRX1569987'), ('GSM2059221', 'SRX1569991'), ('GSM2059218', 'SRX1569988'), ('GSM2059235', 'SRX1570005'), ('GSM2059229', 'SRX1569999'), ('GSM2059232', 'SRX1570002'), ('GSM2059233', 'SRX1570003'), ('GSM2059230', 'SRX1570000'), ('GSM2059224', 'SRX1569994'), ('GSM2059227', 'SRX1569997'), ('GSM2059234', 'SRX1570004'), ('GSM2059228', 'SRX1569998'), ('GSM2059231', 'SRX1570001'), ('GSM2059225', 'SRX1569995'), ('GSM2059219', 'SRX1569989'), ('GSM2059222', 'SRX1569992')]","['Mus musculus', 'Homo sapiens']",['Expression profiling by high throughput sequencing']
26,'GEO',['GSE47921'],'Human adult white matter progenitor cells are multipotent neuroprogenitors identical to adult hippocampal progenitors',"u'Adult neural progenitor cells (aNPCs) are a potential autologous cell source for cell replacement in neurologic diseases such as Parkinson\u2019s disease or stroke or for cell-based gene therapy for neurometabolic diseases. Easy accessibility, long-term expandability and detailed characterization of NPC properties are important requisites for their future translational/clinical applications. aNPC can be isolated from different regions of the adult human brain including the accessible subcortical white matter (aNPCWM), but systematic studies comparing long-term expanded aNPCWM with aNPC from neurogenic brain regions to check for their NPC characteristics and performance are not available. Freshly isolated cells from subcortical white matter and hippocampus (aNPCHIP) expressed oligodendrocyte progenitor cell (OPC) markers such as A2B5, NG2 and OLIG2 in ~20% of cells but no neural stem cell (NSC) markers such CD133 (Prominin1), NESTIN, SOX2 or PAX6. The EGF receptor (EGFR) protein was expressed in 18% of aNPCWM and 7% of aNPCHIP, but only a small fraction of 1 cell out 694 cells from white matter and only 1 out of 1,331 hippocampal cells were able to generate neurospheres. Studies comparing subcortical aNPCWM with their hippocampal counterparts showed that both NPC types expressed mainly markers of glial origin such as NG2, A2B5 and OLIG2, and the NSC/NPC marker Nestin, but no pericyte markers. Both NPC types were able to produce fully mature neurons, astrocytes and oligodendrocytes in comparable amounts to fetal NSC. Whole transcriptome analyses finally confirmed the strong similarity of aNPCWM with aNPCHIP. Our data show that aNPCWM are multipotent NPC with long-term expandability capacity similar to NPC from hippocampus making them an easily accessible source for possible autologous NPC-based treatment strategies. Isolation and propagation of multipotent NPCs. Adult human hippocampal (hip) and subcortical white matter (wm) tissue was obtained from routine epilepsy surgery procedures following informed consent of the subjects. All procedures were in accordance with the Helsinki convention and approved by the Ethical Committee of the University of Dresden (No. 47032006). All subjects underwent high-resolution magnetic resonance imaging excluding tumors and were screened for the presence of infectious disease. In all cases the neuropathological examinations did not reveal evidences for tumor formation. Gene expression Single-channel oligonucleotide microarray analysis. For the gene expression microarray analysis we used the Affimetrix U133A chips containing 22.215 probe sets representing at least 12.905 individual genes. The whole procedure was performed following the manufacturer\u2019s standard protocol (Affimetrix, Santa Clara, CA). For the data processing, normalization was calculated with the GCRMA (GC content corrected Robust Multi-array Analysis) algorithm.'",[],[],[],[],['GPL96'],['[HG-U133A] Affymetrix Human Genome U133A Array'],"['GSM1162429', 'GSM1162432', 'GSM1162430', 'GSM1162433', 'GSM1162427', 'GSM1162428', 'GSM1162431']",['Homo sapiens'],['Expression profiling by array']
27,'GEO',['GSE82101'],'Expression data from human iPSC-NPC',"""Induced pluripotent stem cell-derived neural progenitor cells (iPSC-NPCs) are a promising source of tailor-made cell therapy for neurological diseases. However, tumorigenicity and immunogenicity are major obstacles to translational use. Here we demonstrate epidural therapeutics of human iPSC-NPC grafts after experimental ischemic stroke to avoid surgical damage and intracerebral teratomas. We found that human iPSC-NPCs co-cultured trans-membranously with rat cortical cells subjected to oxygen-glucose deprivation, compared with human mesenchymal stem cells from bone marrow and umbilical cord Wharton's jelly, superiorly enhanced neural survival and growth as well as mitigated astrogliosis. Using comparative whole-genome microarrays and cytokine arrays, we identified a neurorestorative secretome from iPSC-NPCs and neutralization of the enriched cytokines potently abolished the neuroprotective effects in the iPSC-NPC co-cultures. Moreover, we implanted the human iPSC-NPCs epidurally using fibrin glue over the peri-infarct cortex at 7 days following permanent middle cerebral artery occlusion in adult rats. The cell-treated rats showed significant improvement in their paretic forelimb usage and grip strength from 10 days post-transplantation (dpt) onwards compared to the vehicle-treated rats, accompanied by ameliorated infarct/atrophy volumes, inflammatory infiltration and astrogliosis, as well as augmented angiogenesis, oligodendrocyte precursor cells and white matter integrity. Some iPSC-NPCs migrated into the peri-infarct cortex but poorly survived by 21 dpt. This proof-of-concept study demonstrates that a less invasive yet effective epidural delivery route of human iPSC-NPCs may promote functional remodeling of the peri-infarct brain predominantly through distinct paracrine effects.""",[],[],[],[],['GPL570'],['[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array'],['GSM2183464'],['Homo sapiens'],['Expression profiling by array']
28,'GEO',['GSE66724'],'Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis with no increased bleeding risk',"'Atrial fibrillation (AF) is a major risk factor for cardioembolic stroke. Anticoagulant drugs are effective in preventing AF-related stroke. However, the high frequency of anticoagulant-associated major bleeding is a major concern particularly when antiplatelet treatment is simultaneously administered. Here, microarray analysis in peripheral blood cells in eight patients with AF and stroke and eight AF subjects without stroke identified a stroke related gene expression pattern. HSPA1B, which encodes for heat-shock protein 70 kDa (Hsp70), was the most differentially expressed gene. This gene was downregulated in stroke subjects, a finding confirmed further in an independent AF cohort of 200 individuals. Hsp70 knock-out (KO) mice subjected to different thrombotic challenges developed thrombosis significantly earlier than their wild-type (WT) counterparts. In WT mice, Hsp70 inducers (TRC051384, or tubastatin A) delayed thrombus formation. Remarkably, Hsp70 inducers did not increase the bleeding risk even when aspirin was concomitantly administered. Hsp70 induction was associated with an increased vascular thrombomodulin expression, higher circulating levels of activated protein C (APC) upon thrombotic stimulus and increased protection against endothelial apoptosis. Thus, Hsp70 induction is a novel approach to delay thrombus formation with minimal bleeding risk, being especially promising in situations where there is a major bleeding hazard.'",[26976620],['Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk.'],['2016 Jun 1'],"[['Allende M', 'Molina E', 'Guruceaga E', 'Tamayo I', u'Gonz\xe1lez-Porras JR', u'Gonzalez-L\xf3pez TJ', 'Toledo E', 'Rabal O', 'Ugarte A', u'Rold\xe1n V', 'Rivera J', 'Oyarzabal J', 'Montes R', 'Hermida J']]",['GPL570'],['[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array'],"['GSM1630727', 'GSM1630724', 'GSM1630736', 'GSM1630730', 'GSM1630733', 'GSM1630739', 'GSM1630731', 'GSM1630725', 'GSM1630728', 'GSM1630726', 'GSM1630734', 'GSM1630737', 'GSM1630729', 'GSM1630732', 'GSM1630735', 'GSM1630738']",['Homo sapiens'],['Expression profiling by array']
29,'GEO',['GSE68526'],'Peripheral blood transcriptome profiles from an RNA Pilot Study within the United States Health and Retirement Study (HRS)',"'Individual differences in peripheral blood transcriptomes in older adults as a function of demographic, socio-economic, psychological, and health history characteristics.'",[26246388],"['Loneliness, eudaimonia, and the human conserved transcriptional response to adversity.']",['2015 Dec'],"[['Cole SW', 'Levine ME', 'Arevalo JM', 'Ma J', 'Weir DR', 'Crimmins EM']]",['GPL10904'],['Illumina HumanHT-12 V4.0 expression beadchip (gene symbol)'],"['GSM1674342', 'GSM1674365', 'GSM1674388', 'GSM1674425', 'GSM1674385', 'GSM1674408', 'GSM1674325', 'GSM1674362', 'GSM1674428', 'GSM1674368', 'GSM1674322', 'GSM1674345', 'GSM1674405', 'GSM1674382', 'GSM1674351', 'GSM1674328', 'GSM1674397', 'GSM1674374', 'GSM1674431', 'GSM1674411', 'GSM1674334', 'GSM1674348', 'GSM1674371', 'GSM1674394', 'GSM1674354', 'GSM1674417', 'GSM1674414', 'GSM1674391', 'GSM1674331', 'GSM1674320', 'GSM1674360', 'GSM1674403', 'GSM1674380', 'GSM1674377', 'GSM1674400', 'GSM1674314', 'GSM1674337', 'GSM1674420', 'GSM1674357', 'GSM1674383', 'GSM1674423', 'GSM1674363', 'GSM1674317', 'GSM1674340', 'GSM1674412', 'GSM1674329', 'GSM1674426', 'GSM1674349', 'GSM1674366', 'GSM1674409', 'GSM1674343', 'GSM1674432', 'GSM1674326', 'GSM1674389', 'GSM1674406', 'GSM1674429', 'GSM1674386', 'GSM1674323', 'GSM1674352', 'GSM1674346', 'GSM1674369', 'GSM1674335', 'GSM1674358', 'GSM1674398', 'GSM1674415', 'GSM1674332', 'GSM1674355', 'GSM1674315', 'GSM1674375', 'GSM1674338', 'GSM1674361', 'GSM1674384', 'GSM1674372', 'GSM1674418', 'GSM1674395', 'GSM1674392', 'GSM1674378', 'GSM1674381', 'GSM1674421', 'GSM1674364', 'GSM1674407', 'GSM1674393', 'GSM1674324', 'GSM1674370', 'GSM1674321', 'GSM1674344', 'GSM1674413', 'GSM1674427', 'GSM1674424', 'GSM1674367', 'GSM1674390', 'GSM1674404', 'GSM1674401', 'GSM1674318', 'GSM1674341', 'GSM1674430', 'GSM1674410', 'GSM1674387', 'GSM1674319', 'GSM1674416', 'GSM1674347', 'GSM1674422', 'GSM1674399', 'GSM1674339', 'GSM1674316', 'GSM1674330', 'GSM1674327', 'GSM1674350', 'GSM1674373', 'GSM1674313', 'GSM1674396', 'GSM1674336', 'GSM1674433', 'GSM1674419', 'GSM1674333', 'GSM1674356', 'GSM1674402', 'GSM1674379', 'GSM1674376', 'GSM1674353', 'GSM1674359']",['Homo sapiens'],['Expression profiling by array']
30,'GEO',"['GSE71216', 'SRP061426']",'Transcriptome sequencing to identify transcription factor regulatory network and alternative splicing in endothelial cells under VEGF stimulation','Human umbilical vein vascular endothelial cells (HUVECs) are crucial for angiogenesis that benefits functional recovery after cerebral infarction. This study aims to investigate the mechanisms underlying the effects of vascular endothelial growth factor (VEGF) on HUVECs.',[26395122],['Transcriptome Sequencing to Identify Transcription Factor Regulatory Network and Alternative Splicing in Endothelial Cells Under VEGF Stimulation.'],['2016 Feb'],"[['Liu F', 'Gao X', 'Wang J', 'Gao C', 'Li X', 'Li X', 'Gong X', 'Zeng X']]",['GPL16791'],['Illumina HiSeq 2500 (Homo sapiens)'],"[('GSM1830134', 'SRX1115726'), ('GSM1830137', 'SRX1115729'), ('GSM1830135', 'SRX1115727'), ('GSM1830136', 'SRX1115728')]",['Homo sapiens'],['Expression profiling by high throughput sequencing']
31,'GEO',['GSE72642'],"'Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome'","'Blood genomic profiling has been applied to disorders of the blood and various organ systems including brain to elucidate disease mechanisms and identify surrogate disease markers. Since most studies have not examined specific cell types, we performed a preliminary genomic survey of major blood cell types from normal individuals using microarrays. CD4+ T cells, CD8+ T cells, CD19+ B cells, CD56+ natural killer cells, and CD14+ monocytes were negatively selected using the RosetteSep antibody cocktail, while polymorphonuclear leukocytes were separated with density gradient media. Genes differentially expressed by each cell type were identified. To demonstrate the potential use of such cell subtype-specific genomic expression data, a number of the major genes previously reported to be regulated in ischemic stroke, migraine, and Tourette syndrome are shown to be associated with distinct cell populations in blood. These specific gene expression, cell-type-related profiles will need to be confirmed in larger data sets and could be used to study these and many other neurological diseases.'",[16546348],"['Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome.']",['2006 Jun'],"[['Du X', 'Tang Y', 'Xu H', 'Lit L', 'Walker W', 'Ashwood P', 'Gregg JP', 'Sharp FR']]",['GPL570'],['[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array'],"['GSM1867067', 'GSM1867070', 'GSM1867073', 'GSM1867076', 'GSM1867079', 'GSM1867082', 'GSM1867065', 'GSM1867068', 'GSM1867071', 'GSM1867077', 'GSM1867074', 'GSM1867080', 'GSM1867066', 'GSM1867069', 'GSM1867072', 'GSM1867075', 'GSM1867078', 'GSM1867081']",['Homo sapiens'],['Expression profiling by array']
32,'GEO',"['GSE61390', 'SRP047082']",'Genetic Correction and Metabolic Rescue of Pluripotent Cells from Patients with mtDNA',"'Mitochondria are vital due to their principal role in energy production via oxidative phosphorylation (OXPHOS)1. Mitochondria carry their own genome (mtDNA) encoding critical genes involved in OXPHOS, therefore, mtDNA mutations cause fatal or severely debilitating disorders with limited treatment options. 2. Clinical manifestations of mtDNA disease vary based on mutation type and heteroplasmy levels i.e. presence of mutant and normal mtDNA within each cell. 3,4. We evaluated therapeutic concepts of generating genetically corrected pluripotent stem cells for patients with mtDNA mutations. We initially generated multiple iPS cell lines from a patient with mitochondrial encephalomyopathy and stroke-like episodes (MELAS) caused by a heteroplasmic 3243A>G mutation and a patient with Leigh disease carrying a homoplasmic 8993T>G mutation (Leigh-iPS). Due to spontaneous mtDNA segregation in proliferating fibroblasts, isogenic MELAS iPS cell lines were recovered containing exclusively wild type (wt) mtDNA with normal metabolic function. As expected, all iPS cells from the patient with Leigh disease were affected. Using somatic cell nuclear transfer (SCNT; Leigh-NT1), we then simultaneously replaced mutated mtDNA and generated pluripotent stem cells from the Leigh patient fibroblasts. In addition to reversing to a normal 8993G>T, oocyte derived donor mtDNA (human haplotype D4a) in Leigh-NT1 differed from the original haplotype (F1a) at a additional 47 nucleotide sites. Leigh-NT1 cells displayed normal metabolic function compared to impaired oxygen consumption and ATP production in Leigh-iPS cells or parental fibroblasts (Leigh-fib). We conclude that natural segregation of heteroplasmic mtDNA allows the generation of iPS cells with exclusively wild type mtDNA. Moreover, SCNT offers mitochondrial gene replacement strategy for patients with homoplasmic mtDNA disease.'",[26176921],['Metabolic rescue in pluripotent cells from patients with mtDNA disease.'],['2015 Aug 13'],"[['Ma H', 'Folmes CD', 'Wu J', 'Morey R', 'Mora-Castilla S', 'Ocampo A', 'Ma L', 'Poulton J', 'Wang X', 'Ahmed R', 'Kang E', 'Lee Y', 'Hayama T', 'Li Y', 'Van Dyken C', 'Gutierrez NM', 'Tippner-Hedges R', 'Koski A', 'Mitalipov N', 'Amato P', 'Wolf DP', 'Huang T', 'Terzic A', 'Laurent LC', 'Izpisua Belmonte JC', 'Mitalipov S']]","['GPL11154', 'GPL16791']","['Illumina HiSeq 2000 (Homo sapiens)', 'Illumina HiSeq 2500 (Homo sapiens)']","[('GSM1503694', 'SRX700353'), ('GSM1503697', 'SRX700356'), ('GSM1608065', 'SRX874252'), ('GSM1608019', 'SRX873946'), ('GSM1503677', 'SRX700336'), ('GSM1503680', 'SRX700339'), ('GSM1608008', 'SRX873935'), ('GSM1503683', 'SRX700342'), ('GSM1503686', 'SRX700345'), ('GSM1608007', 'SRX873934'), ('GSM1608005', 'SRX873932'), ('GSM1503699', 'SRX700358'), ('GSM1503679', 'SRX700338'), ('GSM1608064', 'SRX874251'), ('GSM1503682', 'SRX700341'), ('GSM1503685', 'SRX700344'), ('GSM1503688', 'SRX700347'), ('GSM1608016', 'SRX873943'), ('GSM1608013', 'SRX873940'), ('GSM1608010', 'SRX873937'), ('GSM1503691', 'SRX700350'), ('GSM1503684', 'SRX700343'), ('GSM1503687', 'SRX700346'), ('GSM1608012', 'SRX873939'), ('GSM1608009', 'SRX873936'), ('GSM1608006', 'SRX873933'), ('GSM1503690', 'SRX700349'), ('GSM1608011', 'SRX873938'), ('GSM1503693', 'SRX700352'), ('GSM1503696', 'SRX700355'), ('GSM1608017', 'SRX873944'), ('GSM1608018', 'SRX873945'), ('GSM1608014', 'SRX873941'), ('GSM1608015', 'SRX873942'), ('GSM1503689', 'SRX700348'), ('GSM1608020', 'SRX873947'), ('GSM1503698', 'SRX700357'), ('GSM1503678', 'SRX700337'), ('GSM1503692', 'SRX700351'), ('GSM1503695', 'SRX700354'), ('GSM1503681', 'SRX700340'), ('GSM1608066', 'SRX874253'), ('GSM1608063', 'SRX874250')]",['Homo sapiens'],"['Expression profiling by high throughput sequencing', 'Third-party reanalysis']"
33,'GEO',['GSE37587'],'Gene Expression Profiling of Ischemic Stroke at 0-24 hours and 24-48 hours after known onset of symptoms','The objective of this study was to provide insight to the molecular mechanisms chaging in the peripheral blood after acute ischemic cerebrovascular syndrome.',[25124890],['A genomic profile of the immune response to stroke with implications for stroke recovery.'],['2015 May'],"[['Barr TL', 'VanGilder R', 'Rellick S', 'Brooks SD', 'Doll DN', 'Lucke-Wold AN', 'Chen D', 'Denvir J', 'Warach S', 'Singleton A', 'Matarin M']]",['GPL6883'],['Illumina HumanRef-8 v3.0 expression beadchip'],"['GSM922909', 'GSM922946', 'GSM922923', 'GSM922943', 'GSM922929', 'GSM922906', 'GSM922926', 'GSM922903', 'GSM922949', 'GSM922895', 'GSM922892', 'GSM922932', 'GSM922915', 'GSM922889', 'GSM922912', 'GSM922952', 'GSM922918', 'GSM922941', 'GSM922935', 'GSM922938', 'GSM922924', 'GSM922921', 'GSM922944', 'GSM922901', 'GSM922927', 'GSM922950', 'GSM922898', 'GSM922904', 'GSM922890', 'GSM922947', 'GSM922953', 'GSM922887', 'GSM922910', 'GSM922930', 'GSM922907', 'GSM922896', 'GSM922913', 'GSM922936', 'GSM922919', 'GSM922893', 'GSM922899', 'GSM922922', 'GSM922905', 'GSM922933', 'GSM922939', 'GSM922916', 'GSM922902', 'GSM922925', 'GSM922945', 'GSM922931', 'GSM922908', 'GSM922954', 'GSM922942', 'GSM922928', 'GSM922951', 'GSM922911', 'GSM922934', 'GSM922948', 'GSM922914', 'GSM922891', 'GSM922940', 'GSM922937', 'GSM922888', 'GSM922917', 'GSM922894', 'GSM922900', 'GSM922897', 'GSM922920']",['Homo sapiens'],['Expression profiling by array']
34,'GEO',['GSE58294'],'Gene Expression Following Cardioembolic Stroke',"'Blood from subjects with cardioembolic stroke and controls was collected, and the RNA extracted was interrogated and whole genome U133 Affymetrix Arrays. Twenty-three control samples and sixty-nine cardioembolic stroke samples were assayed.'",[25036109],['Gene expression in peripheral immune cells following cardioembolic stroke is sexually dimorphic.'],['2014'],"[['Stamova B', 'Jickling GC', 'Ander BP', 'Zhan X', 'Liu D', 'Turner R', 'Ho C', 'Khoury JC', 'Bushnell C', 'Pancioli A', 'Jauch EC', 'Broderick JP', 'Sharp FR']]",['GPL570'],['[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array'],"['GSM1406036', 'GSM1406096', 'GSM1406119', 'GSM1406050', 'GSM1406073', 'GSM1406076', 'GSM1406053', 'GSM1406113', 'GSM1406033', 'GSM1406056', 'GSM1406093', 'GSM1406116', 'GSM1406082', 'GSM1406070', 'GSM1406105', 'GSM1406059', 'GSM1406099', 'GSM1406039', 'GSM1406062', 'GSM1406085', 'GSM1406122', 'GSM1406079', 'GSM1406078', 'GSM1406101', 'GSM1406124', 'GSM1406102', 'GSM1406042', 'GSM1406118', 'GSM1406041', 'GSM1406098', 'GSM1406121', 'GSM1406055', 'GSM1406081', 'GSM1406035', 'GSM1406061', 'GSM1406058', 'GSM1406038', 'GSM1406044', 'GSM1406104', 'GSM1406064', 'GSM1406067', 'GSM1406110', 'GSM1406087', 'GSM1406090', 'GSM1406047', 'GSM1406107', 'GSM1406084', 'GSM1406063', 'GSM1406123', 'GSM1406040', 'GSM1406066', 'GSM1406043', 'GSM1406060', 'GSM1406046', 'GSM1406086', 'GSM1406109', 'GSM1406092', 'GSM1406095', 'GSM1406083', 'GSM1406049', 'GSM1406072', 'GSM1406103', 'GSM1406075', 'GSM1406089', 'GSM1406106', 'GSM1406069', 'GSM1406115', 'GSM1406091', 'GSM1406114', 'GSM1406112', 'GSM1406052', 'GSM1406108', 'GSM1406111', 'GSM1406088', 'GSM1406045', 'GSM1406068', 'GSM1406048', 'GSM1406071', 'GSM1406034', 'GSM1406037', 'GSM1406094', 'GSM1406117', 'GSM1406120', 'GSM1406051', 'GSM1406065', 'GSM1406054', 'GSM1406100', 'GSM1406077', 'GSM1406097', 'GSM1406080', 'GSM1406074', 'GSM1406057']",['Homo sapiens'],['Expression profiling by array']
35,'GEO',['GSE48424'],'Severe preeclampsia: new blood circulating biomarkers',"'Background: Preeclampsia (PE) is a placental disease characterized by hypertension and proteinuria in pregnant women, which is associated with a high maternal and infantile morbidity. However, circulating biomarkers able to predict the prognosis of PE are lacking. Methods: Thirty-eight women were included in the study. They consisted of 19 patients with PE (13 with severe PE and 6 women with non-severe PE) and 19 gestational age-matched normal pregnancy controls. We measured coagulation pathway, endothelial responses and microparticle release and circulating gene expression in PE patient groups and normotensive controls. Results: The measurement of markers associated with coagulation pathway, endothelial activation and circulating microparticles enabled to discriminate PE from normal pregnancy but were not sufficient to distinguish severe from non-severe PE. PE patients also exhibited a specific transcriptional program distinct from that of control women and subtle differences were observed between severe and non-severe PE. Functional annotation of the up-modulated signature in PE highlighted two main functions related to ribosome and complement. Importantly, we found that 8 genes were specifically up-modulated in severe preeclampsia. Among these genes, the expression of VSIG4 was significantly increased in patients with severe preeclampsia in comparison with controls and patients with non-severe preeclampsia. Conclusion: Using transcriptional signatures of blood samples, we identified the gene encoding the estrogen receptor as a potential diagnostic marker of severe preeclampsia. In addition, the determination of this gene may improve the prognostic assessment of severe preeclampsia.'",[24349325],['Evaluation of current and new biomarkers in severe preeclampsia: a microarray approach reveals the VSIG4 gene as a potential blood biomarker.'],['2013'],"[['Textoris J', 'Ivorra D', 'Ben Amara A', 'Sabatier F', u'M\xe9nard JP', 'Heckenroth H', 'Bretelle F', 'Mege JL']]",['GPL6480'],['Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version)'],"['GSM1177783', 'GSM1177789', 'GSM1177809', 'GSM1177786', 'GSM1177806', 'GSM1177797', 'GSM1177780', 'GSM1177777', 'GSM1177803', 'GSM1177800', 'GSM1177784', 'GSM1177798', 'GSM1177804', 'GSM1177781', 'GSM1177778', 'GSM1177801', 'GSM1177795', 'GSM1177792', 'GSM1177779', 'GSM1177793', 'GSM1177776', 'GSM1177799', 'GSM1177796', 'GSM1177807', 'GSM1177811', 'GSM1177790', 'GSM1177810', 'GSM1177787', 'GSM1177788', 'GSM1177802', 'GSM1177794', 'GSM1177808', 'GSM1177791', 'GSM1177782', 'GSM1177805', 'GSM1177785']",['Homo sapiens'],['Expression profiling by array']
36,'GEO',"['GSE56267', 'SRP040622']",'The age and genomic integrity of neurons after cortical stroke in humans',"'It has been unclear whether ischemic stroke induces neurogenesis or neuronal DNA-rearrangements in the human neocortex. We show here that neither is the case, using immunohistochemistry, transcriptome-, genome- and ploidy-analyses, and determination of nuclear bomb test-derived 14C-concentration in neuronal DNA. A large proportion of cortical neurons display DNA-fragmentation and DNA-repair short time after stroke, whereas neurons at chronic stages after stroke show DNA-integrity, demonstrating the relevance of an intact genome for survival.'",[24747576],['The age and genomic integrity of neurons after cortical stroke in humans.'],['2014 Jun'],"[['Huttner HB', 'Bergmann O', 'Salehpour M', u'R\xe1cz A', 'Tatarishvili J', 'Lindgren E', 'Csonka T', 'Csiba L', u'Hortob\xe1gyi T', u'M\xe9hes G', 'Englund E', 'Solnestam BW', 'Zdunek S', 'Scharenberg C', u'Str\xf6m L', u'St\xe5hl P', 'Sigurgeirsson B', 'Dahl A', 'Schwab S', 'Possnert G', 'Bernard S', 'Kokaia Z', 'Lindvall O', 'Lundeberg J', u'Fris\xe9n J']]",['GPL11154'],['Illumina HiSeq 2000 (Homo sapiens)'],"[('GSM1357996', 'SRX501846'), ('GSM1357999', 'SRX501849'), ('GSM1358005', 'SRX501855'), ('GSM1358002', 'SRX501852'), ('GSM1358001', 'SRX501851'), ('GSM1357998', 'SRX501848'), ('GSM1358004', 'SRX501854'), ('GSM1358006', 'SRX501856'), ('GSM1357995', 'SRX501845'), ('GSM1358003', 'SRX501853'), ('GSM1357994', 'SRX501844'), ('GSM1358000', 'SRX501850'), ('GSM1357997', 'SRX501847')]",['Homo sapiens'],['Expression profiling by high throughput sequencing']
37,'GEO',['GSE46269'],'miRNAs involved in regulating embolic stroke recovery following spontaneous reperfusion','This SuperSeries is composed of the SubSeries listed below.',[23823624],['microRNAs Involved in Regulating Spontaneous Recovery in Embolic Stroke Model.'],['2013'],"[['Liu FJ', 'Lim KY', 'Kaur P', 'Sepramaniam S', 'Armugam A', 'Wong PT', 'Jeyaseelan K']]","['GPL17042', 'GPL6101']","['miRCURY LNA microRNA Array, v.11.0 - hsa, mmu & rno [miRNA ID version]', 'Illumina ratRef-12 v1.0 expression beadchip']","['GSM1127883', 'GSM1127880', 'GSM1127886', 'GSM1127874', 'GSM1127871', 'GSM1127877', 'GSM1127878', 'GSM1127881', 'GSM1127875', 'GSM1127869', 'GSM1127889', 'GSM1127870', 'GSM1127872', 'GSM1127873', 'GSM1127876', 'GSM1127887', 'GSM1127884', 'GSM1127868', 'GSM1127888', 'GSM1127885', 'GSM1127882', 'GSM1127879']","['Human alphaherpesvirus 1', 'Macaca mulatta polyomavirus 1', 'Rattus norvegicus', 'JC polyomavirus', 'Murid gammaherpesvirus 4', 'Homo sapiens', 'Human betaherpesvirus 5', 'Murid betaherpesvirus 1', 'Human immunodeficiency virus 1', 'Mus musculus', 'Human gammaherpesvirus 4', 'Human gammaherpesvirus 8', 'Human polyomavirus 1']","['Non-coding RNA profiling by array', 'Expression profiling by array']"
38,'GEO',['GSE47728'],'Global peripheral blood gene expression study [HumanHT-12 V4.0]',"""Samples were collected from 'control participants' of the Heart and Vascular Health (HVH) study that constitutes a group of population based case control studies of myocardial infarction (MI), stroke, venous thromboembolism (VTE), and atrial fibrillation (AF) conducted among 30-79 year old members of Group Health, a large integrated health care organization in Washington State.""",[24013639],['Systematic identification of trans eQTLs as putative drivers of known disease associations.'],['2013 Oct'],"[['Westra HJ', 'Peters MJ', 'Esko T', 'Yaghootkar H', 'Schurmann C', 'Kettunen J', 'Christiansen MW', 'Fairfax BP', 'Schramm K', 'Powell JE', 'Zhernakova A', 'Zhernakova DV', 'Veldink JH', 'Van den Berg LH', 'Karjalainen J', 'Withoff S', 'Uitterlinden AG', 'Hofman A', 'Rivadeneira F', ""Hoen PAC'"", 'Reinmaa E', 'Fischer K', 'Nelis M', 'Milani L', 'Melzer D', 'Ferrucci L', 'Singleton AB', 'Hernandez DG', 'Nalls MA', 'Homuth G', 'Nauck M', 'Radke D', u'V\xf6lker U', 'Perola M', 'Salomaa V', 'Brody J', 'Suchy-Dicey A', 'Gharib SA', 'Enquobahrie DA', 'Lumley T', 'Montgomery GW', 'Makino S', 'Prokisch H', 'Herder C', 'Roden M', 'Grallert H', 'Meitinger T', 'Strauch K', 'Li Y', 'Jansen RC', 'Visscher PM', 'Knight JC', 'Psaty BM', 'Ripatti S', 'Teumer A', 'Frayling TM', 'Metspalu A', 'van Meurs JBJ', 'Franke L']]",['GPL10558'],['Illumina HumanHT-12 V4.0 expression beadchip'],"['GSM1298604', 'GSM1298544', 'GSM1298498', 'GSM1298581', 'GSM1298392', 'GSM1298475', 'GSM1298558', 'GSM1298521', 'GSM1298438', 'GSM1298461', 'GSM1298415', 'GSM1298601', 'GSM1298481', 'GSM1298518', 'GSM1298398', 'GSM1298435', 'GSM1298455', 'GSM1298564', 'GSM1298458', 'GSM1298541', 'GSM1298395', 'GSM1298584', 'GSM1298561', 'GSM1298478', 'GSM1298538', 'GSM1298501', 'GSM1298607', 'GSM1298418', 'GSM1298446', 'GSM1298572', 'GSM1298452', 'GSM1298406', 'GSM1298449', 'GSM1298429', 'GSM1298555', 'GSM1298489', 'GSM1298532', 'GSM1298426', 'GSM1298535', 'GSM1298472', 'GSM1298595', 'GSM1298512', 'GSM1298578', 'GSM1298552', 'GSM1298509', 'GSM1298389', 'GSM1298469', 'GSM1298412', 'GSM1298575', 'GSM1298592', 'GSM1298495', 'GSM1298432', 'GSM1298410', 'GSM1298539', 'GSM1298516', 'GSM1298433', 'GSM1298386', 'GSM1298598', 'GSM1298409', 'GSM1298515', 'GSM1298492', 'GSM1298456', 'GSM1298387', 'GSM1298493', 'GSM1298559', 'GSM1298599', 'GSM1298470', 'GSM1298553', 'GSM1298576', 'GSM1298513', 'GSM1298453', 'GSM1298407', 'GSM1298536', 'GSM1298430', 'GSM1298533', 'GSM1298556', 'GSM1298393', 'GSM1298484', 'GSM1298590', 'GSM1298507', 'GSM1298596', 'GSM1298401', 'GSM1298476', 'GSM1298424', 'GSM1298530', 'GSM1298496', 'GSM1298390', 'GSM1298413', 'GSM1298602', 'GSM1298567', 'GSM1298450', 'GSM1298579', 'GSM1298473', 'GSM1298447', 'GSM1298587', 'GSM1298421', 'GSM1298504', 'GSM1298610', 'GSM1298527', 'GSM1298404', 'GSM1298487', 'GSM1298593', 'GSM1298510', 'GSM1298427', 'GSM1298384', 'GSM1298467', 'GSM1298490', 'GSM1298573', 'GSM1298548', 'GSM1298444', 'GSM1298465', 'GSM1298571', 'GSM1298464', 'GSM1298550', 'GSM1298511', 'GSM1298570', 'GSM1298594', 'GSM1298488', 'GSM1298388', 'GSM1298524', 'GSM1298471', 'GSM1298485', 'GSM1298547', 'GSM1298441', 'GSM1298591', 'GSM1298574', 'GSM1298451', 'GSM1298405', 'GSM1298534', 'GSM1298428', 'GSM1298468', 'GSM1298402', 'GSM1298425', 'GSM1298554', 'GSM1298508', 'GSM1298448', 'GSM1298385', 'GSM1298408', 'GSM1298491', 'GSM1298531', 'GSM1298442', 'GSM1298562', 'GSM1298568', 'GSM1298439', 'GSM1298545', 'GSM1298462', 'GSM1298551', 'GSM1298528', 'GSM1298445', 'GSM1298419', 'GSM1298525', 'GSM1298459', 'GSM1298436', 'GSM1298565', 'GSM1298482', 'GSM1298588', 'GSM1298542', 'GSM1298522', 'GSM1298416', 'GSM1298479', 'GSM1298499', 'GSM1298502', 'GSM1298585', 'GSM1298396', 'GSM1298608', 'GSM1298423', 'GSM1298543', 'GSM1298582', 'GSM1298605', 'GSM1298397', 'GSM1298466', 'GSM1298420', 'GSM1298549', 'GSM1298526', 'GSM1298443', 'GSM1298523', 'GSM1298440', 'GSM1298606', 'GSM1298546', 'GSM1298519', 'GSM1298529', 'GSM1298422', 'GSM1298399', 'GSM1298505', 'GSM1298400', 'GSM1298483', 'GSM1298506', 'GSM1298391', 'GSM1298566', 'GSM1298414', 'GSM1298460', 'GSM1298520', 'GSM1298586', 'GSM1298437', 'GSM1298497', 'GSM1298480', 'GSM1298603', 'GSM1298609', 'GSM1298503', 'GSM1298517', 'GSM1298411', 'GSM1298494', 'GSM1298600', 'GSM1298383', 'GSM1298577', 'GSM1298597', 'GSM1298417', 'GSM1298500', 'GSM1298569', 'GSM1298403', 'GSM1298514', 'GSM1298394', 'GSM1298463', 'GSM1298486', 'GSM1298589', 'GSM1298474', 'GSM1298580', 'GSM1298557', 'GSM1298434', 'GSM1298457', 'GSM1298563', 'GSM1298540', 'GSM1298537', 'GSM1298560', 'GSM1298583', 'GSM1298454', 'GSM1298477', 'GSM1298431']",['Homo sapiens'],['Expression profiling by array']
39,'GEO',['GSE47727'],'Global peripheral blood gene expression study [HumanHT-12 V3.0]',"""Samples were collected from 'control participants' of the Heart and Vascular Health (HVH) study that constitutes a group of population based case control studies of myocardial infarction (MI), stroke, venous thromboembolism (VTE), and atrial fibrillation (AF) conducted among 30-79 year old members of Group Health, a large integrated health care organization in Washington State.""",[24013639],['Systematic identification of trans eQTLs as putative drivers of known disease associations.'],['2013 Oct'],"[['Westra HJ', 'Peters MJ', 'Esko T', 'Yaghootkar H', 'Schurmann C', 'Kettunen J', 'Christiansen MW', 'Fairfax BP', 'Schramm K', 'Powell JE', 'Zhernakova A', 'Zhernakova DV', 'Veldink JH', 'Van den Berg LH', 'Karjalainen J', 'Withoff S', 'Uitterlinden AG', 'Hofman A', 'Rivadeneira F', ""Hoen PAC'"", 'Reinmaa E', 'Fischer K', 'Nelis M', 'Milani L', 'Melzer D', 'Ferrucci L', 'Singleton AB', 'Hernandez DG', 'Nalls MA', 'Homuth G', 'Nauck M', 'Radke D', u'V\xf6lker U', 'Perola M', 'Salomaa V', 'Brody J', 'Suchy-Dicey A', 'Gharib SA', 'Enquobahrie DA', 'Lumley T', 'Montgomery GW', 'Makino S', 'Prokisch H', 'Herder C', 'Roden M', 'Grallert H', 'Meitinger T', 'Strauch K', 'Li Y', 'Jansen RC', 'Visscher PM', 'Knight JC', 'Psaty BM', 'Ripatti S', 'Teumer A', 'Frayling TM', 'Metspalu A', 'van Meurs JBJ', 'Franke L']]",['GPL6947'],['Illumina HumanHT-12 V3.0 expression beadchip'],"['GSM1298331', 'GSM1298308', 'GSM1298285', 'GSM1298368', 'GSM1298345', 'GSM1298262', 'GSM1298288', 'GSM1298348', 'GSM1298325', 'GSM1298265', 'GSM1298371', 'GSM1298351', 'GSM1298328', 'GSM1298305', 'GSM1298268', 'GSM1298282', 'GSM1298322', 'GSM1298299', 'GSM1298276', 'GSM1298359', 'GSM1298316', 'GSM1298302', 'GSM1298339', 'GSM1298362', 'GSM1298279', 'GSM1298319', 'GSM1298296', 'GSM1298256', 'GSM1298259', 'GSM1298277', 'GSM1298365', 'GSM1298342', 'GSM1298360', 'GSM1298303', 'GSM1298280', 'GSM1298363', 'GSM1298323', 'GSM1298300', 'GSM1298257', 'GSM1298346', 'GSM1298260', 'GSM1298263', 'GSM1298366', 'GSM1298283', 'GSM1298340', 'GSM1298326', 'GSM1298320', 'GSM1298343', 'GSM1298354', 'GSM1298271', 'GSM1298251', 'GSM1298294', 'GSM1298357', 'GSM1298274', 'GSM1298317', 'GSM1298334', 'GSM1298254', 'GSM1298337', 'GSM1298318', 'GSM1298297', 'GSM1298341', 'GSM1298258', 'GSM1298311', 'GSM1298291', 'GSM1298314', 'GSM1298335', 'GSM1298355', 'GSM1298295', 'GSM1298272', 'GSM1298361', 'GSM1298338', 'GSM1298252', 'GSM1298315', 'GSM1298332', 'GSM1298309', 'GSM1298358', 'GSM1298275', 'GSM1298286', 'GSM1298298', 'GSM1298278', 'GSM1298255', 'GSM1298312', 'GSM1298289', 'GSM1298306', 'GSM1298292', 'GSM1298267', 'GSM1298369', 'GSM1298350', 'GSM1298290', 'GSM1298266', 'GSM1298352', 'GSM1298329', 'GSM1298372', 'GSM1298349', 'GSM1298293', 'GSM1298353', 'GSM1298270', 'GSM1298269', 'GSM1298273', 'GSM1298287', 'GSM1298253', 'GSM1298336', 'GSM1298313', 'GSM1298364', 'GSM1298344', 'GSM1298261', 'GSM1298321', 'GSM1298367', 'GSM1298330', 'GSM1298333', 'GSM1298370', 'GSM1298310', 'GSM1298347', 'GSM1298264', 'GSM1298356', 'GSM1298327', 'GSM1298304', 'GSM1298281', 'GSM1298284', 'GSM1298307', 'GSM1298324', 'GSM1298301']",['Homo sapiens'],['Expression profiling by array']
40,'GEO',['GSE38571'],'Integrated transcriptomic and epigenomic analysis of primary human lung cell differentiation','This SuperSeries is composed of the SubSeries listed below.',"[23818859, 25343132]","['Integrated transcriptomic and epigenomic analysis of primary human lung epithelial cell differentiation.', 'Transcriptomic Profiling of Primary Alveolar Epithelial Cell Differentiation in Human and Rat.']","['2013 Jun', '2014 Dec 1']","[['Marconett CN', 'Zhou B', 'Rieger ME', 'Selamat SA', 'Dubourd M', 'Fang X', 'Lynch SK', 'Stueve TR', 'Siegmund KD', 'Berman BP', 'Borok Z', 'Laird-Offringa IA'], ['Marconett CN', 'Zhou B', 'Siegmund KD', 'Borok Z', 'Laird-Offringa IA']]","['GPL6101', 'GPL9115', 'GPL10558']","['Illumina ratRef-12 v1.0 expression beadchip', 'Illumina Genome Analyzer II (Homo sapiens)', 'Illumina HumanHT-12 V4.0 expression beadchip']","['GSM945658', ('GSM992734', 'SRX180896'), 'GSM945661', 'GSM945655', 'GSM945667', 'GSM945644', ('GSM992731', 'SRX180893'), 'GSM945670', 'GSM945647', 'GSM945664', 'GSM945653', 'GSM945673', 'GSM945656', 'GSM945650', ('GSM992732', 'SRX180894'), 'GSM945662', ('GSM992735', 'SRX180897'), 'GSM945659', 'GSM945648', 'GSM945671', 'GSM945651', 'GSM945645', 'GSM945668', 'GSM945654', 'GSM945665', 'GSM945657', ('GSM992733', 'SRX180895'), 'GSM945674', 'GSM945660', ('GSM992736', 'SRX180898'), 'GSM945663', 'GSM945666', 'GSM945643', 'GSM945646', 'GSM945649', 'GSM945672', 'GSM945652', 'GSM945669']","['Rattus norvegicus', 'Homo sapiens']","['Expression profiling by array', 'Genome binding/occupancy profiling by high throughput sequencing']"
41,'GEO',['GSE38569'],'Integrated transcriptomic and epigenomic analysis of primary human lung cell differentiation (Human)',"'Analysis of gene expression during differentiation of alveolar epithelial type 2 (AT2) cells into AT1 cells. Timepoints taken at Day 0 (AT2 cell), Days 2, 4, and 6 in culture (differentiating) and Day 8 in culture (AT1-like cells).'","[23818859, 25343132]","['Integrated transcriptomic and epigenomic analysis of primary human lung epithelial cell differentiation.', 'Transcriptomic Profiling of Primary Alveolar Epithelial Cell Differentiation in Human and Rat.']","['2013 Jun', '2014 Dec 1']","[['Marconett CN', 'Zhou B', 'Rieger ME', 'Selamat SA', 'Dubourd M', 'Fang X', 'Lynch SK', 'Stueve TR', 'Siegmund KD', 'Berman BP', 'Borok Z', 'Laird-Offringa IA'], ['Marconett CN', 'Zhou B', 'Siegmund KD', 'Borok Z', 'Laird-Offringa IA']]",['GPL10558'],['Illumina HumanHT-12 V4.0 expression beadchip'],"['GSM945644', 'GSM945650', 'GSM945647', 'GSM945659', 'GSM945656', 'GSM945653', 'GSM945645', 'GSM945651', 'GSM945648', 'GSM945654', 'GSM945657', 'GSM945649', 'GSM945646', 'GSM945655', 'GSM945643', 'GSM945652', 'GSM945658']",['Homo sapiens'],['Expression profiling by array']
42,'GEO',['GSE45878'],'Affymetrix expression data from GTEx',"'The Genotype-Tissue Expression (GTEx) project is a collaborative effort that aims to identify correlations between genotype and tissue-specific gene expression levels that will help identify regions of the genome that influence whether and how much a gene is expressed. GTEx is funded through the Common Fund, and managed by the NIH Office of the Director in partnership with the National Human Genome Research Institute, National Institute of Mental Health, the National Cancer Institute, the National Center for Biotechnology Information at the National Library of Medicine, the National Heart, Lung and Blood Institute, the National Institute on Drug Abuse, and the National Institute of Neurological Diseases and Stroke, all part of NIH. This series of 837 samples represents multiple tissues collected from 102 GTEX donors and 1 control cell line. In total, 30 tissue sites are represented including Adipose, Artery, Heart, Lung, Whole Blood, Muscle, Skin, and 11 brain subregions. RNA-seq expression data, robust clinical data, pathological annotations, and genotypes are also available for these samples from dbGaP (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000424.v2.p1) and the GTEx portal (www.broadinstitute.org/gtex). While GTEx is no longer generating Affymetrix expression data, donor enrollment continues and is expected to reach 1,000 by the end of 2015. Updates to the GTEx data in dbGaP and the GTEx Portal will be made periodically. contributor: GTEx Laboratory, Data Analysis, and Coordinating Center (LDACC) contributor: The Broad Institute of MIT and Harvard (LDACC PIs: Kristin Ardlie and Gaddy Getz)'",[],[],[],[],['GPL16977'],['[HuGene-1_1-st] Affymetrix Human Gene 1.1 ST Array [HuGene11stv1_Hs_ENSG version 14.1.0]'],"['GSM1117728', 'GSM1117811', 'GSM1117516', 'GSM1117433', 'GSM1117230', 'GSM1117313', 'GSM1117539', 'GSM1117917', 'GSM1117599', 'GSM1117622', 'GSM1117373', 'GSM1117456', 'GSM1117931', 'GSM1117977', 'GSM1117645', 'GSM1117396', 'GSM1117705', 'GSM1117562', 'GSM1117894', 'GSM1117682', 'GSM1117954', 'GSM1117479', 'GSM1117848', 'GSM1117765', 'GSM1117871', 'GSM1117788', 'GSM1117937', 'GSM1117914', 'GSM1117854', 'GSM1117244', 'GSM1117147', 'GSM1117410', 'GSM1117327', 'GSM1117350', 'GSM1117184', 'GSM1117161', 'GSM1117207', 'GSM1117267', 'GSM1117290', 'GSM1117181', 'GSM1117619', 'GSM1117559', 'GSM1117642', 'GSM1117416', 'GSM1117499', 'GSM1117702', 'GSM1117725', 'GSM1117785', 'GSM1117665', 'GSM1117748', 'GSM1117771', 'GSM1117808', 'GSM1117144', 'GSM1117831', 'GSM1117167', 'GSM1117951', 'GSM1117204', 'GSM1117891', 'GSM1117453', 'GSM1117250', 'GSM1117582', 'GSM1117227', 'GSM1117536', 'GSM1117287', 'GSM1117247', 'GSM1117353', 'GSM1117688', 'GSM1117310', 'GSM1117639', 'GSM1117333', 'GSM1117974', 'GSM1117330', 'GSM1117459', 'GSM1117393', 'GSM1117390', 'GSM1117413', 'GSM1117868', 'GSM1117436', 'GSM1117519', 'GSM1117722', 'GSM1117496', 'GSM1117370', 'GSM1117476', 'GSM1117187', 'GSM1117957', 'GSM1117473', 'GSM1117270', 'GSM1117874', 'GSM1117556', 'GSM1117307', 'GSM1117224', 'GSM1117579', 'GSM1117662', 'GSM1117934', 'GSM1117745', 'GSM1117911', 'GSM1117164', 'GSM1117851', 'GSM1117542', 'GSM1117828', 'GSM1117602', 'GSM1117625', 'GSM1117685', 'GSM1117908', 'GSM1117768', 'GSM1117636', 'GSM1117708', 'GSM1117791', 'GSM1117719', 'GSM1117742', 'GSM1117696', 'GSM1117968', 'GSM1117945', 'GSM1117885', 'GSM1117802', 'GSM1117862', 'GSM1117825', 'GSM1117576', 'GSM1117659', 'GSM1117779', 'GSM1117221', 'GSM1117424', 'GSM1117507', 'GSM1117530', 'GSM1117613', 'GSM1117304', 'GSM1117590', 'GSM1117198', 'GSM1117218', 'GSM1117341', 'GSM1117241', 'GSM1117281', 'GSM1117195', 'GSM1117447', 'GSM1117278', 'GSM1117364', 'GSM1117301', 'GSM1117822', 'GSM1117845', 'GSM1117553', 'GSM1117470', 'GSM1117387', 'GSM1117673', 'GSM1117493', 'GSM1117756', 'GSM1117527', 'GSM1117324', 'GSM1117430', 'GSM1117347', 'GSM1117928', 'GSM1117175', 'GSM1117633', 'GSM1117716', 'GSM1117258', 'GSM1117739', 'GSM1117158', 'GSM1117533', 'GSM1117819', 'GSM1117444', 'GSM1117361', 'GSM1117407', 'GSM1117925', 'GSM1117215', 'GSM1117905', 'GSM1117513', 'GSM1117384', 'GSM1117321', 'GSM1117799', 'GSM1117510', 'GSM1117427', 'GSM1117593', 'GSM1117616', 'GSM1117762', 'GSM1117699', 'GSM1117298', 'GSM1117264', 'GSM1117550', 'GSM1117902', 'GSM1117201', 'GSM1117404', 'GSM1117487', 'GSM1117656', 'GSM1117653', 'GSM1117450', 'GSM1117736', 'GSM1117759', 'GSM1117842', 'GSM1117202', 'GSM1117467', 'GSM1117488', 'GSM1117865', 'GSM1117155', 'GSM1117594', 'GSM1117490', 'GSM1117308', 'GSM1117805', 'GSM1117573', 'GSM1117238', 'GSM1117965', 'GSM1117344', 'GSM1117596', 'GSM1117679', 'GSM1117882', 'GSM1117261', 'GSM1117367', 'GSM1117676', 'GSM1117262', 'GSM1117368', 'GSM1117782', 'GSM1117971', 'GSM1117285', 'GSM1117391', 'GSM1117474', 'GSM1117677', 'GSM1117948', 'GSM1117156', 'GSM1117178', 'GSM1117700', 'GSM1117179', 'GSM1117889', 'GSM1117723', 'GSM1117806', 'GSM1117866', 'GSM1117570', 'GSM1117284', 'GSM1117760', 'GSM1117405', 'GSM1117783', 'GSM1117428', 'GSM1117225', 'GSM1117863', 'GSM1117511', 'GSM1117888', 'GSM1117534', 'GSM1117411', 'GSM1117697', 'GSM1117909', 'GSM1117617', 'GSM1117388', 'GSM1117471', 'GSM1117969', 'GSM1117494', 'GSM1117577', 'GSM1117780', 'GSM1117803', 'GSM1117886', 'GSM1117322', 'GSM1117345', 'GSM1117926', 'GSM1117451', 'GSM1117640', 'GSM1117743', 'GSM1117239', 'GSM1117972', 'GSM1117826', 'GSM1117949', 'GSM1117849', 'GSM1117176', 'GSM1117328', 'GSM1117282', 'GSM1117557', 'GSM1117531', 'GSM1117843', 'GSM1117932', 'GSM1117614', 'GSM1117199', 'GSM1117259', 'GSM1117305', 'GSM1117637', 'GSM1117720', 'GSM1117365', 'GSM1117766', 'GSM1117448', 'GSM1117554', 'GSM1117660', 'GSM1117946', 'GSM1117929', 'GSM1117514', 'GSM1117597', 'GSM1117800', 'GSM1117574', 'GSM1117620', 'GSM1117703', 'GSM1117680', 'GSM1117906', 'GSM1117952', 'GSM1117786', 'GSM1117302', 'GSM1117869', 'GSM1117385', 'GSM1117182', 'GSM1117491', 'GSM1117408', 'GSM1117468', 'GSM1117245', 'GSM1117668', 'GSM1117222', 'GSM1117774', 'GSM1117880', 'GSM1117170', 'GSM1117276', 'GSM1117465', 'GSM1117751', 'GSM1117382', 'GSM1117162', 'GSM1117548', 'GSM1117834', 'GSM1117571', 'GSM1117857', 'GSM1117654', 'GSM1117940', 'GSM1117336', 'GSM1117253', 'GSM1117359', 'GSM1117717', 'GSM1117537', 'GSM1117823', 'GSM1117442', 'GSM1117219', 'GSM1117325', 'GSM1117431', 'GSM1117960', 'GSM1117608', 'GSM1117963', 'GSM1117877', 'GSM1117691', 'GSM1117454', 'GSM1117634', 'GSM1117714', 'GSM1117591', 'GSM1117657', 'GSM1117740', 'GSM1117797', 'GSM1117763', 'GSM1117846', 'GSM1117159', 'GSM1117193', 'GSM1117299', 'GSM1117242', 'GSM1117216', 'GSM1117265', 'GSM1117551', 'GSM1117502', 'GSM1117585', 'GSM1117651', 'GSM1117348', 'GSM1117525', 'GSM1117674', 'GSM1117757', 'GSM1117631', 'GSM1117903', 'GSM1117820', 'GSM1117737', 'GSM1117419', 'GSM1117923', 'GSM1117356', 'GSM1117462', 'GSM1117900', 'GSM1117379', 'GSM1117485', 'GSM1117568', 'GSM1117794', 'GSM1117273', 'GSM1117439', 'GSM1117153', 'GSM1117545', 'GSM1117173', 'GSM1117711', 'GSM1117196', 'GSM1117734', 'GSM1117817', 'GSM1117840', 'GSM1117150', 'GSM1117777', 'GSM1117233', 'GSM1117256', 'GSM1117482', 'GSM1117279', 'GSM1117565', 'GSM1117883', 'GSM1117588', 'GSM1117671', 'GSM1117980', 'GSM1117860', 'GSM1117694', 'GSM1117966', 'GSM1117296', 'GSM1117648', 'GSM1117362', 'GSM1117151', 'GSM1117402', 'GSM1117508', 'GSM1117754', 'GSM1117190', 'GSM1117469', 'GSM1117236', 'GSM1117376', 'GSM1117755', 'GSM1117319', 'GSM1117522', 'GSM1117552', 'GSM1117605', 'GSM1117293', 'GSM1117838', 'GSM1117342', 'GSM1117399', 'GSM1117861', 'GSM1117628', 'GSM1117234', 'GSM1117425', 'GSM1117257', 'GSM1117340', 'GSM1117446', 'GSM1117363', 'GSM1117529', 'GSM1117635', 'GSM1117157', 'GSM1117213', 'GSM1117443', 'GSM1117549', 'GSM1117921', 'GSM1117210', 'GSM1117317', 'GSM1117423', 'GSM1117316', 'GSM1117217', 'GSM1117337', 'GSM1117240', 'GSM1117526', 'GSM1117505', 'GSM1117609', 'GSM1117323', 'GSM1117632', 'GSM1117611', 'GSM1117941', 'GSM1117897', 'GSM1117837', 'GSM1117655', 'GSM1117758', 'GSM1117422', 'GSM1117339', 'GSM1117445', 'GSM1117528', 'GSM1117943', 'GSM1117731', 'GSM1117920', 'GSM1117814', 'GSM1117715', 'GSM1117738', 'GSM1117546', 'GSM1117844', 'GSM1117864', 'GSM1117652', 'GSM1117841', 'GSM1117343', 'GSM1117629', 'GSM1117947', 'GSM1117426', 'GSM1117712', 'GSM1117924', 'GSM1117532', 'GSM1117386', 'GSM1117735', 'GSM1117818', 'GSM1117672', 'GSM1117589', 'GSM1117612', 'GSM1117695', 'GSM1117778', 'GSM1117967', 'GSM1117944', 'GSM1117718', 'GSM1117174', 'GSM1117801', 'GSM1117280', 'GSM1117566', 'GSM1117197', 'GSM1117400', 'GSM1117483', 'GSM1117360', 'GSM1117277', 'GSM1117154', 'GSM1117383', 'GSM1117260', 'GSM1117303', 'GSM1117506', 'GSM1117466', 'GSM1117489', 'GSM1117300', 'GSM1117214', 'GSM1117406', 'GSM1117237', 'GSM1117692', 'GSM1117320', 'GSM1117171', 'GSM1117254', 'GSM1117414', 'GSM1117964', 'GSM1117881', 'GSM1117194', 'GSM1117927', 'GSM1117572', 'GSM1117775', 'GSM1117912', 'GSM1117858', 'GSM1117649', 'GSM1117211', 'GSM1117904', 'GSM1117732', 'GSM1117698', 'GSM1117781', 'GSM1117437', 'GSM1117815', 'GSM1117520', 'GSM1117543', 'GSM1117935', 'GSM1117463', 'GSM1117497', 'GSM1117798', 'GSM1117626', 'GSM1117486', 'GSM1117569', 'GSM1117829', 'GSM1117592', 'GSM1117675', 'GSM1117821', 'GSM1117623', 'GSM1117729', 'GSM1117603', 'GSM1117709', 'GSM1117420', 'GSM1117683', 'GSM1117503', 'GSM1117706', 'GSM1117789', 'GSM1117812', 'GSM1117231', 'GSM1117403', 'GSM1117895', 'GSM1117517', 'GSM1117185', 'GSM1117291', 'GSM1117509', 'GSM1117208', 'GSM1117795', 'GSM1117314', 'GSM1117901', 'GSM1117397', 'GSM1117600', 'GSM1117615', 'GSM1117884', 'GSM1117835', 'GSM1117918', 'GSM1117177', 'GSM1117938', 'GSM1117915', 'GSM1117892', 'GSM1117809', 'GSM1117832', 'GSM1117606', 'GSM1117248', 'GSM1117331', 'GSM1117852', 'GSM1117297', 'GSM1117394', 'GSM1117500', 'GSM1117380', 'GSM1117311', 'GSM1117354', 'GSM1117334', 'GSM1117460', 'GSM1117417', 'GSM1117523', 'GSM1117440', 'GSM1117726', 'GSM1117288', 'GSM1117958', 'GSM1117746', 'GSM1117165', 'GSM1117205', 'GSM1117228', 'GSM1117540', 'GSM1117563', 'GSM1117188', 'GSM1117646', 'GSM1117271', 'GSM1117669', 'GSM1117922', 'GSM1117752', 'GSM1117955', 'GSM1117899', 'GSM1117351', 'GSM1117148', 'GSM1117792', 'GSM1117434', 'GSM1117457', 'GSM1117169', 'GSM1117275', 'GSM1117192', 'GSM1117395', 'GSM1117294', 'GSM1117580', 'GSM1117663', 'GSM1117377', 'GSM1117898', 'GSM1117875', 'GSM1117686', 'GSM1117769', 'GSM1117878', 'GSM1117480', 'GSM1117586', 'GSM1117166', 'GSM1117749', 'GSM1117268', 'GSM1117872', 'GSM1117772', 'GSM1117374', 'GSM1117855', 'GSM1117604', 'GSM1117961', 'GSM1117484', 'GSM1117401', 'GSM1117687', 'GSM1117770', 'GSM1117710', 'GSM1117793', 'GSM1117816', 'GSM1117189', 'GSM1117212', 'GSM1117876', 'GSM1117295', 'GSM1117978', 'GSM1117272', 'GSM1117318', 'GSM1117378', 'GSM1117292', 'GSM1117398', 'GSM1117375', 'GSM1117172', 'GSM1117458', 'GSM1117504', 'GSM1117481', 'GSM1117564', 'GSM1117975', 'GSM1117666', 'GSM1117689', 'GSM1117919', 'GSM1117979', 'GSM1117896', 'GSM1117873', 'GSM1117251', 'GSM1117587', 'GSM1117670', 'GSM1117693', 'GSM1117790', 'GSM1117610', 'GSM1117357', 'GSM1117643', 'GSM1117773', 'GSM1117796', 'GSM1117713', 'GSM1117501', 'GSM1117478', 'GSM1117561', 'GSM1117145', 'GSM1117381', 'GSM1117371', 'GSM1117168', 'GSM1117477', 'GSM1117274', 'GSM1117607', 'GSM1117191', 'GSM1117560', 'GSM1117583', 'GSM1117584', 'GSM1117667', 'GSM1117879', 'GSM1117690', 'GSM1117839', 'GSM1117959', 'GSM1117312', 'GSM1117335', 'GSM1117229', 'GSM1117146', 'GSM1117252', 'GSM1117266', 'GSM1117289', 'GSM1117349', 'GSM1117575', 'GSM1117455', 'GSM1117372', 'GSM1117741', 'GSM1117658', 'GSM1117243', 'GSM1117627', 'GSM1117183', 'GSM1117733', 'GSM1117160', 'GSM1117429', 'GSM1117346', 'GSM1117544', 'GSM1117567', 'GSM1117263', 'GSM1117369', 'GSM1117664', 'GSM1117853', 'GSM1117650', 'GSM1117286', 'GSM1117235', 'GSM1117249', 'GSM1117521', 'GSM1117936', 'GSM1117332', 'GSM1117232', 'GSM1117452', 'GSM1117338', 'GSM1117438', 'GSM1117315', 'GSM1117421', 'GSM1117355', 'GSM1117624', 'GSM1117152', 'GSM1117461', 'GSM1117558', 'GSM1117392', 'GSM1117707', 'GSM1117950', 'GSM1117475', 'GSM1117678', 'GSM1117255', 'GSM1117973', 'GSM1117541', 'GSM1117761', 'GSM1117890', 'GSM1117498', 'GSM1117638', 'GSM1117581', 'GSM1117784', 'GSM1117867', 'GSM1117578', 'GSM1117647', 'GSM1117661', 'GSM1117744', 'GSM1117684', 'GSM1117209', 'GSM1117970', 'GSM1117942', 'GSM1117767', 'GSM1117366', 'GSM1117850', 'GSM1117149', 'GSM1117186', 'GSM1117472', 'GSM1117163', 'GSM1117246', 'GSM1117449', 'GSM1117352', 'GSM1117555', 'GSM1117269', 'GSM1117956', 'GSM1117753', 'GSM1117776', 'GSM1117730', 'GSM1117859', 'GSM1117813', 'GSM1117893', 'GSM1117856', 'GSM1117836', 'GSM1117358', 'GSM1117681', 'GSM1117764', 'GSM1117644', 'GSM1117962', 'GSM1117787', 'GSM1117953', 'GSM1117870', 'GSM1117464', 'GSM1117750', 'GSM1117418', 'GSM1117524', 'GSM1117441', 'GSM1117547', 'GSM1117939', 'GSM1117916', 'GSM1117833', 'GSM1117630', 'GSM1117847', 'GSM1117976', 'GSM1117326', 'GSM1117409', 'GSM1117206', 'GSM1117432', 'GSM1117515', 'GSM1117538', 'GSM1117492', 'GSM1117598', 'GSM1117220', 'GSM1117226', 'GSM1117180', 'GSM1117203', 'GSM1117747', 'GSM1117830', 'GSM1117807', 'GSM1117512', 'GSM1117535', 'GSM1117618', 'GSM1117641', 'GSM1117724', 'GSM1117309', 'GSM1117595', 'GSM1117415', 'GSM1117435', 'GSM1117721', 'GSM1117913', 'GSM1117701', 'GSM1117827', 'GSM1117495', 'GSM1117518', 'GSM1117601', 'GSM1117804', 'GSM1117223', 'GSM1117329', 'GSM1117283', 'GSM1117910', 'GSM1117200', 'GSM1117306', 'GSM1117887', 'GSM1117389', 'GSM1117933', 'GSM1117412', 'GSM1117930', 'GSM1117907', 'GSM1117621', 'GSM1117824', 'GSM1117704', 'GSM1117727', 'GSM1117810']",['Homo sapiens'],['Expression profiling by array']
43,'GEO',['GSE36487'],'Expression data from human vascular smooth muscle cells exposed to minimally oxidized (mox) LDL',"'Atherosclerosis (AT) is a chronic inflammatory disease characterized by the accumulation of inflammatory cells, lipoproteins and fibrous tissue in the walls of arteries. AT is the primary cause of heart attacks and stroke and the leading cause of death in westernized countries. To date, the pathogenesis of AT is not well-defined. Studies have shown that the dedifferentiation of contractile and quiescent vascular smooth muscle cells (SMC) to the proliferative, migratory and synthetic phenotype in the intima is pivotal for the onset and progression of AT. To further delineate the mechanisms underlying the pathogenesis of AT, we have analyzed the early molecular pathways and networks of SMC phenotype transformation as induced by the presence of minimally-oxidized LDL (moxLDL).'",[],[],[],[],['GPL96'],['[HG-U133A] Affymetrix Human Genome U133A Array'],"['GSM894979', 'GSM894977', 'GSM894978']",['Homo sapiens'],['Expression profiling by array']
44,'GEO',['GSE22255'],'Blood genomic expression profile for ischemic stroke (IS)',"u'Stroke is a \u201cbrain attack\u201d cutting off vital blood, and consequently the nutrients and oxygen vital to the brain cells that control everything we do. Stroke is a complex disease with unclear pathogenesis resulting from environmental and genetic factors. To better understand IS\xb4s etiology, we performed genomic expression profiling of patients and controls.'",[22453632],['TTC7B emerges as a novel risk factor for ischemic stroke through the convergence of several genome-wide approaches.'],['2012 Jun'],"[['Krug T', 'Gabriel JP', 'Taipa R', 'Fonseca BV', 'Domingues-Montanari S', 'Fernandez-Cadenas I', 'Manso H', 'Gouveia LO', 'Sobral J', 'Albergaria I', 'Gaspar G', u'Jim\xe9nez-Conde J', 'Rabionet R', 'Ferro JM', 'Montaner J', 'Vicente AM', 'Silva MR', 'Matos I', 'Lopes G', 'Oliveira SA']]",['GPL570'],['[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array'],"['GSM554044', 'GSM554027', 'GSM554024', 'GSM554047', 'GSM554038', 'GSM554015', 'GSM554021', 'GSM554035', 'GSM554018', 'GSM554041', 'GSM554039', 'GSM554016', 'GSM554022', 'GSM554019', 'GSM554042', 'GSM554030', 'GSM554053', 'GSM554036', 'GSM554050', 'GSM554033', 'GSM554034', 'GSM554017', 'GSM554014', 'GSM554037', 'GSM554048', 'GSM554052', 'GSM554025', 'GSM554045', 'GSM554031', 'GSM554049', 'GSM554051', 'GSM554028', 'GSM554029', 'GSM554020', 'GSM554043', 'GSM554040', 'GSM554032', 'GSM554046', 'GSM554023', 'GSM554026']",['Homo sapiens'],['Expression profiling by array']
45,'GEO',['GSE27041'],'OXPHOS complex I deficiency leads to transcriptional changes of the Nrf2-Keap1 pathway and selenoproteins.',"'Defective complex I (CI) is the most common type of oxidative phosphorylation (OXPHOS) disease in patients, with an incidence of 1 in 5,000 live births. Complex I deficiency can present in infancy or early adulthood and shows a wide variety of clinical manifestations, including Leigh syndrome, (cardio)myopathy, hypotonia, stroke, ataxia and lactic acidosis. A number of critical processes and factors, like superoxide production, calcium homeostasis, mitochondrial membrane potential and mitochondrial morphology, are known to be involved in clinical CI deficiency, but not all factors are yet known and a complete picture is lacking. Therefore, whole genome gene expression profiling was performed in fibroblasts of CI deficient patients and controls, comparing glycolytic and oxidative conditions. Linear regression and pathway analysis identified a number of key adaptive processes.'",[22033105],['Transcriptional changes in OXPHOS complex I deficiency are related to anti-oxidant pathways and could explain the disturbed calcium homeostasis.'],['2012 Jul'],"[['Voets AM', 'Huigsloot M', 'Lindsey PJ', 'Leenders AM', 'Koopman WJ', 'Willems PH', 'Rodenburg RJ', 'Smeitink JA', 'Smeets HJ']]",['GPL570'],['[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array'],"['GSM666043', 'GSM666026', 'GSM666029', 'GSM666032', 'GSM666035', 'GSM666025', 'GSM666028', 'GSM666031', 'GSM666034', 'GSM666037', 'GSM666040', 'GSM666033', 'GSM666036', 'GSM666039', 'GSM666038', 'GSM666042', 'GSM666041', 'GSM666024', 'GSM666030', 'GSM666027']",['Homo sapiens'],['Expression profiling by array']
46,'GEO',['GSE29932'],"'To identify specific glycosylated structures on brain endothelial cells that mediate rolling, adhesion, and diapedesis of leukocytes in the brain'","'The blood-brain barrier (BBB) dynamically controls and maintains a precisely balanced brain microenvironment necessary for reliable functioning. It is made up of highly specialized endothelial cells (ECs) in the lining of the vascular wall. These ECs are surrounded by the basal lamina, astrocytic perivascular endfeet, pericytes, microglia and neuronal processes that have been shown to contribute to barrier function1. In essence, the brain endothelium limits both transcellular and paracellular passage of cells and molecules into the central nervous system (CNS). Transcellular passage of hydrophilic molecules is limited due to a low rate of transcytotic vesicles, an extremely low pinocytotic activity, expression of active efflux transporters, and high metabolic activity. Paracellular diffusion of hydrophilic molecules and trafficking of immune cells is restricted by a network of tight junctions (TJs)2-5. Due to these characteristics, the BBB is able to protect the CNS from sudden changes in blood composition and uncontrolled influx of immune cells. In a large number of neuro-inflammatory diseases, an impaired function and an opening of the BBB are observed. In diseases of the CNS like multiple sclerosis or stroke or after brain trauma, the BBB becomes inflamed (mediated by for example reactive oxygen species (ROS) and hypoxia) and its function severely impaired which gives rise to enhanced cellular infiltration, thus contributing to tissue damage and neurological deficits. Due to the specialized nature of brain ECs, transmigration of leukocytes through cerebrovascular endothelium is likely to differ from that in other vascular beds. Generally, the transmigration process is closely controlled by the interaction of leukocytes with the endothelial surface followed by low velocity rolling, arrest, firm adhesion, and finally transmigration. For the diapedesis of immune cells across the cerebral vasculature a re-arrangement of the cytoskeleton and opening of the TJ complexes is required to allow cells to pass into the sub endothelial space. In the initial step of the adhesive cascade leukocytes adhere to the endothelium with low affinity. This adhesion is mediated by several members of the selectin family and their corresponding ligands. Despite the low affinity of these interactions, resulting contact of leukocytes with the endothelium leads to further activation of both cell types and finally transmigration of the leukocytes through the BBB6,7.'",[],[],[],[],['GPL11095'],['[GLYCOv3_Hs] Custom Affymetrix Glyco v3 GeneChip'],"['GSM740984', 'GSM740993', 'GSM740990', 'GSM740987', 'GSM740989', 'GSM740986', 'GSM740992', 'GSM740991', 'GSM740988', 'GSM740985']",['Homo sapiens'],['Expression profiling by array']
47,'GEO',['GSE13353'],'Comparison of gene expression between ruptured and unruptured human intracranial aneurysms',"u'Background and Purpose Aneurysmal subarachnoid hemorrhage, almost always from saccular intracranial aneurysm (sIA), is a devastating form of stroke that affects working age population. Cellular and molecular mechanisms predisposing to the rupture of the sIA wall are largely unknown. Such knowledge would facilitate the design of novel diagnostic tools and therapies for the sIA disease. Methods We compared the whole genome expression profile of eleven ruptured sIA wall samples, resected at a median of 15 hours after rupture, to that of eight unruptured ones. Signaling pathways enriched in the ruptured sIA walls were identified with bioinformatic analyses. Their transcriptional control was predicted in silico by seeking the enrichment of conserved transcription factor binding sites in the promoter regions of differentially expressed genes. Results Overall, 686 genes were significantly upregulated and 740 downregulated in the ruptured sIA walls. Significantly upregulated biological processes included: response to turbulent blood flow; chemotaxis; leukocyte migration; oxidative stress; vascular remodelling; and extracellular matrix degradation. Toll like receptor (TLR) signalling and NF-\u03baB, HIF1A and ETS transcription factor binding sites were significantly enriched among the upregulated genes. Conclusions We identified pathways and candidate genes associated to the rupture of human sIA wall. These results provide a molecular basis analysis (a) to identify rupture-prone sIAs and (b) to prevent their rupture. Novel measures to prevent the rupture of sIA wall may include inhibition of response to turbulent blood flow, leukocyte migration, TLR signalling, or blockade of NF-\u03baB, HIF1A and ETS transcription factors.'",[21336216],"[u'Upregulated signaling pathways in ruptured human saccular intracranial aneurysm wall: an emerging regulative role of Toll-like receptor signaling and nuclear factor-\u03baB, hypoxia-inducible factor-1A, and ETS transcription factors.']",['2011 Jun'],"[['Kurki MI', u'H\xe4kkinen SK', u'Fr\xf6sen J', 'Tulamo R', 'von und zu Fraunberg M', 'Wong G', 'Tromp G', u'Niemel\xe4 M', 'Hernesniemi J', u'J\xe4\xe4skel\xe4inen JE', u'Yl\xe4-Herttuala S']]",['GPL570'],['[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array'],"['GSM337109', 'GSM337112', 'GSM337103', 'GSM337106', 'GSM337120', 'GSM337104', 'GSM337107', 'GSM337118', 'GSM337115', 'GSM337119', 'GSM337113', 'GSM337102', 'GSM337116', 'GSM337110', 'GSM337117', 'GSM337114', 'GSM337108', 'GSM337111', 'GSM337105']",['Homo sapiens'],['Expression profiling by array']
48,'GEO',['GSE25414'],'Expression data from human blood samples',"'Genetic factors contribute to the development of ischemic stroke but their identity remains largely unknown. We tested the association with ischemic stroke of 210 single nucleotide polymorphisms (SNPs) associated with pathways functionally related to stroke. We observed an association between the rs7956957 SNP in LRP1 and next performed microarrays analysis in healthy individuals to investigate possible associations of LRP genotypes with the expression of other genes. Twelve blood samples were obtained from twelve different healthy subjects carrying different genotypes for the rs7956957 SNP of the LRP1 gene (GG, CG or CC).'",[21311749],['Brain perihematoma genomic profile following spontaneous human intracerebral hemorrhage.'],['2011 Feb 2'],"[['Rosell A', 'Vilalta A', u'Garc\xeda-Berrocoso T', u'Fern\xe1ndez-Cadenas I', 'Domingues-Montanari S', 'Cuadrado E', 'Delgado P', u'Rib\xf3 M', u'Mart\xednez-S\xe1ez E', 'Ortega-Aznar A', 'Montaner J']]",['GPL570'],['[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array'],"['GSM624036', 'GSM624039', 'GSM624042', 'GSM624035', 'GSM624038', 'GSM624041', 'GSM624044', 'GSM624040', 'GSM624043', 'GSM624037', 'GSM624045', 'GSM624034']",['Homo sapiens'],['Expression profiling by array']
49,'GEO',['GSE24095'],'Human postmortem hippocampus: Major depressive disorder (MDD) vs. Control',"'We examined the genetic profile of postmortem brain (hippocampal) samples; 15 brains from patients diagnosed with MDD were matched to brains from healthy subjects based on gender, race and age. Gene expression profiles in the dentate gyrus and CA1 subregions of the hippocampus were assessed by cDNA hybridization to 48K human HEEBO whole genome microarrays (Microarray, Inc).'","[20953200, 22339950]","['A negative regulator of MAP kinase causes depressive behavior.', 'Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects.']","['2010 Nov', '2013 Feb']","[['Duric V', 'Banasr M', 'Licznerski P', 'Schmidt HD', 'Stockmeier CA', 'Simen AA', 'Newton SS', 'Duman RS'], ['Duric V', 'Banasr M', 'Stockmeier CA', 'Simen AA', 'Newton SS', 'Overholser JC', 'Jurjus GJ', 'Dieter L', 'Duman RS']]",['GPL10907'],['Microarrays Inc. Human Genomic 49K MI Ready Array [HEEBO]'],"['GSM593097', 'GSM593094', 'GSM593091', 'GSM593080', 'GSM593103', 'GSM593100', 'GSM593083', 'GSM593079', 'GSM593102', 'GSM593099', 'GSM593088', 'GSM593096', 'GSM593085', 'GSM593108', 'GSM593082', 'GSM593105', 'GSM593107', 'GSM593084', 'GSM593104', 'GSM593081', 'GSM593101', 'GSM593087', 'GSM593093', 'GSM593090', 'GSM593092', 'GSM593098', 'GSM593089', 'GSM593086', 'GSM593095', 'GSM593106']",['Homo sapiens'],['Expression profiling by array']
50,'GEO',['GSE22688'],'Differential endothelial cell gene expression by African Americans versus Caucasian Americans: A possible contribution to health disparity in vascular disease and cancer',"u'Background: African Americans (AA) have increased burdens of cardiovascular disease and cancer compared to Caucasian Americans (CA). This study addresses the possibility that genetic differences affecting the biology of the vascular endothelium could be a factor contributing to this health disparity. Methods: From self-identified, healthy, 20-29 year old AA (n=21) and CA (n=17), we established cultures of blood outgrowth endothelial cells (BOEC) and applied microarray profiling. BOEC have never been exposed to in vivo influences, and their gene expression reflects culture conditions (meticulously controlled) and donor genetics. Analysis used two distinct approaches. Significance Analysis of Microarray, a FDR-based test, identified significant differential expression of single genes. Gene Set Enrichment Analysis examined expression of pre-determined gene sets that survey each of nine biological systems relevant to endothelial cell biology. Results: At the highly stringent threshold of FDR=0, we identified 31 single genes that were differentially expressed, 4 higher and 27 lower in AA. \u201cPSPH\u201d exhibited the greatest fold-change (AA>CA), but this was entirely accounted for by a homolog (PSPHL) hidden within the PSPH probe set. Among other significantly different genes were: for AA>CA, SOS1, AMFR, FGFR3; and for AA<CA, ARVCF, BIN3, EIF4B. Many more (221 transcripts for 204 genes) were differentially expressed at the more customary, less stringent threshold of FDR<.05. Using the biological systems approach, we identified shear response biology as being significantly altered for AA versus CA. It detected an apparent tonic increase of expression (AA>CA) for 46/157 genes within that system. Conclusions: The most significant single gene changes detected for AA involved genes having substantial, known roles in endothelial biology. Biological systems analysis suggested that shear stress response, a critical regulator of endothelial function and vascular homeostasis, may be different between AA and CA. These results potentially have direct implications for the role of endothelial cells in both vascular disease (e.g., hypertension and stroke) and cancer (via angiogenesis). The present findings are consistent with our overarching hypothesis that genetic influences stemming from ancestral continent-of-origin could impact upon endothelial cell biology and thereby contribute to disparity of vascular-related disease burden amongst AA.'",[21223544],['Differential endothelial cell gene expression by African Americans versus Caucasian Americans: a possible contribution to health disparity in vascular disease and cancer.'],['2011 Jan 11'],"[['Wei P', 'Milbauer LC', 'Enenstein J', 'Nguyen J', 'Pan W', 'Hebbel RP']]",['GPL96'],['[HG-U133A] Affymetrix Human Genome U133A Array'],"['GSM562332', 'GSM562312', 'GSM562329', 'GSM562309', 'GSM562326', 'GSM562320', 'GSM562343', 'GSM562306', 'GSM562323', 'GSM562307', 'GSM562327', 'GSM562324', 'GSM562341', 'GSM562318', 'GSM562321', 'GSM562335', 'GSM562338', 'GSM562315', 'GSM562339', 'GSM562322', 'GSM562342', 'GSM562336', 'GSM562313', 'GSM562330', 'GSM562319', 'GSM562333', 'GSM562310', 'GSM562316', 'GSM562340', 'GSM562317', 'GSM562337', 'GSM562314', 'GSM562308', 'GSM562311', 'GSM562334', 'GSM562331', 'GSM562325', 'GSM562328']",['Homo sapiens'],['Expression profiling by array']
51,'GEO',['GSE16561'],'Gene expression analysis of peripheral whole blood RNA following ischemic stroke',"'The purpose of this project was to elucidate gene expression in the peripheral whole blood of acute ischemic stroke patients to identify a panel of genes for the diagnosis of acute ischemic stroke. Peripheral blood samples were collected in Paxgene Blood RNA tubes from stroke patients who were >18 years of age with MRI diagnosed ischemic stroke and controls who were non-stroke neurologically healthy. The results suggest a panel of genes can be used to diagnose ischemic stroke, and provide information about the biological pathways involved in the response to acute ischemic stroke in humans.'","[20837969, 28446746, 29263821]","['Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling.', 'Peripheral blood AKAP7 expression as an early marker for lymphocyte-mediated post-stroke blood brain barrier disruption.', 'Machine-learning approach identifies a pattern of gene expression in peripheral blood that can accurately detect ischaemic stroke.']","['2010 Sep 14', '2017 Apr 26', '2016']","[['Barr TL', 'Conley Y', 'Ding J', 'Dillman A', 'Warach S', 'Singleton A', 'Matarin M'], [""O'Connell GC"", 'Treadway MB', 'Petrone AB', 'Tennant CS', 'Lucke-Wold N', 'Chantler PD', 'Barr TL'], [""O'Connell GC"", 'Petrone AB', 'Treadway MB', 'Tennant CS', 'Lucke-Wold N', 'Chantler PD', 'Barr TL']]",['GPL6883'],['Illumina HumanRef-8 v3.0 expression beadchip'],"['GSM416580', 'GSM416557', 'GSM416534', 'GSM416537', 'GSM416574', 'GSM416531', 'GSM416554', 'GSM416577', 'GSM416548', 'GSM416571', 'GSM416528', 'GSM416551', 'GSM416545', 'GSM416588', 'GSM416565', 'GSM416568', 'GSM416589', 'GSM416572', 'GSM416529', 'GSM416532', 'GSM416549', 'GSM416552', 'GSM416569', 'GSM416586', 'GSM416560', 'GSM416583', 'GSM416563', 'GSM416543', 'GSM416566', 'GSM416546', 'GSM416567', 'GSM416590', 'GSM416544', 'GSM416540', 'GSM416547', 'GSM416564', 'GSM416587', 'GSM416584', 'GSM416535', 'GSM416558', 'GSM416538', 'GSM416561', 'GSM416541', 'GSM416575', 'GSM416581', 'GSM416555', 'GSM416579', 'GSM416578', 'GSM416542', 'GSM416585', 'GSM416539', 'GSM416562', 'GSM416576', 'GSM416570', 'GSM416582', 'GSM416573', 'GSM416536', 'GSM416559', 'GSM416530', 'GSM416553', 'GSM416533', 'GSM416556', 'GSM416550']",['Homo sapiens'],['Expression profiling by array']
52,'GEO',['GSE21899'],'Global Gene Expression Profiles in Cultured Skin Fibroblasts Derived from Patients with Gaucher Disease',"'This work presents the discovery of genes that are dysregulated in patients with Type I and Type III Gaucher Disease. It provides insight into the unique pathogenesis of these phenotypes, improved diagnostic accuracy and potential novel therapies for these patients.'",[],[],[],[],['GPL571'],['[HG-U133A_2] Affymetrix Human Genome U133A 2.0 Array'],"['GSM544727', 'GSM544730', 'GSM544738', 'GSM544739', 'GSM544736', 'GSM544733', 'GSM544740', 'GSM544734', 'GSM544737', 'GSM544731', 'GSM544729', 'GSM544728', 'GSM544735', 'GSM544732']",['Homo sapiens'],['Expression profiling by array']
53,'GEO',['GSE18296'],'Gene Expression Profiling of an Immortalized Human Neural Stem Cell Line HB1.F3',"'Neural stem cells (NSC) with self-renewal and multipotent properties serve as an ideal cell source for transplantation to treat spinal cord injury, stroke, and neurodegenerative diseases. To efficiently induce neuronal lineage cells from NSC for neuron replacement therapy, we should clarify the intrinsic genetic programs involved in a time and place-specific regulation of human NSC differentiation. Recently, we established an immortalized human NSC clone HB1.F3 to provide an unlimited NSC source applicable to genetic manipulation for cell-based therapy. To investigate a role of neurogenin 1 (Ngn1), a proneural basic helix-loop-helix (bHLH) transcription factor, in human NSC differentiation, we established a clone derived from F3 stably overexpressing Ngn1. Genome-wide gene expression profiling identified 250 upregulated genes and 338 downregulated genes in Ngn1-overexpressing F3 cells (F3-Ngn1) versus wild-type F3 cells (F3-WT). Notably, leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5), a novel stem cell marker, showed a robust increase in F3-Ngn1.'",[19813087],"['Stable expression of neurogenin 1 induces LGR5, a novel stem cell marker, in an immortalized human neural stem cell line HB1.F3.']",['2010 Apr'],"[['Satoh J', 'Obayashi S', 'Tabunoki H', 'Wakana T', 'Kim SU']]",['GPL6244'],['[HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version]'],"['GSM456722', 'GSM456725', 'GSM456723', 'GSM456724']",['Homo sapiens'],['Expression profiling by array']
54,'GEO',['GSE9877'],'Genetic Endothelial Systems Biology of Sickle Stroke Risk',"'Genetic differences in endothelial biology could underlie development of phenotypic heterogeneity amongst individuals afflicted with vascular diseases. We obtained BOEC (blood outgrowth endothelial cells) from 20 subjects with sickle cell anemia (age 4-19) shown to be either at-risk (n=11) or not-at-risk (n=9) for ischemic stroke due to, respectively, having or not having occlusive disease at the Circle of Willis (CoW). Gene expression profiling identified no significant single gene differences between the two groups, as expected. However, analysis of Biological Systems Scores, using gene sets that were pre-determined to survey each of nine biological systems, showed that only changes in inflammation signaling are characteristic of the at-risk subjects, as supported by multiple statistical approaches Keywords: disease status analysis'",[18156497],['Genetic endothelial systems biology of sickle stroke risk.'],['2008 Apr 1'],"[['Chang Milbauer L', 'Wei P', 'Enenstein J', 'Jiang A', 'Hillery CA', 'Scott JP', 'Nelson SC', 'Bodempudi V', 'Topper JN', 'Yang RB', 'Hirsch B', 'Pan W', 'Hebbel RP']]",['GPL96'],['[HG-U133A] Affymetrix Human Genome U133A Array'],"['GSM249463', 'GSM249426', 'GSM249466', 'GSM249443', 'GSM249446', 'GSM249469', 'GSM249435', 'GSM249449', 'GSM249429', 'GSM249452', 'GSM249455', 'GSM249432', 'GSM249458', 'GSM249461', 'GSM249438', 'GSM249464', 'GSM249441', 'GSM249467', 'GSM249444', 'GSM249430', 'GSM249470', 'GSM249447', 'GSM249450', 'GSM249427', 'GSM249453', 'GSM249433', 'GSM249425', 'GSM249456', 'GSM249459', 'GSM249436', 'GSM249442', 'GSM249445', 'GSM249454', 'GSM249462', 'GSM249439', 'GSM249448', 'GSM249465', 'GSM249471', 'GSM249451', 'GSM249428', 'GSM249431', 'GSM249457', 'GSM249460', 'GSM249468', 'GSM249440', 'GSM249434', 'GSM249437']",['Homo sapiens'],['Expression profiling by array']
55,'GEO',['GSE9391'],'Gene expression in brain following stroke',"'We have used microarrays to investigate the changes in gene expression at various times after stroke. Our findings reported that gene expression screening can detect known and unknown transcriptional features of stroke. Keywords: time course, disease state analysis'",[17997827],['A microarray study of gene and protein regulation in human and rat brain following middle cerebral artery occlusion.'],['2007 Nov 12'],"[['Mitsios N', 'Saka M', 'Krupinski J', 'Pennucci R', 'Sanfeliu C', 'Wang Q', 'Rubio F', 'Gaffney J', 'Kumar P', 'Kumar S', 'Sullivan M', 'Slevin M']]",['GPL127'],['Atlas Human 1.2 Array (Cat. #7850-1)'],"['GSM239108', 'GSM239105', 'GSM239103', 'GSM239106', 'GSM239107', 'GSM239104']",['Homo sapiens'],['Expression profiling by array']
56,'GEO',['GSE3860'],u'Comparison of Hutchinson\u2013Gilford Progeria Syndrome fibroblast cell lines to control fibroblast cell lines',"u'Hutchinson\u2013Gilford progeria syndrome (HGPS) is a rare genetic disease with widespread phenotypic features resembling premature aging. HGPS was recently shown to be caused by dominant mutations in the LMNA gene, resulting in the in-frame deletion of 50 amino acids near the carboxyl terminus of the encoded lamin A protein. Children with this disease typically succumb to myocardial infarction or stroke caused by severe atherosclerosis at an average age of 13 years. To elucidate further the molecular pathogenesis of this disease, we compared the gene expression patterns of three HGPS fibroblast cell lines heterozygous for the LMNA mutation with three normal, age-matched cell lines. We defined a set of 361 genes (1.1% of the approximately 33 000 genes analyzed) that showed at least a 2-fold, statistically significant change. The most prominent categories encode transcription factors and extracellular matrix proteins, many of which are known to function in the tissues severely affected in HGPS. The most affected gene, MEOX2/GAX, is a homeobox transcription factor implicated as a negative regulator of mesodermal tissue proliferation. Thus, at the gene expression level, HGPS shows the hallmarks of a developmental disorder affecting mesodermal and mesenchymal cell lineages. The identification of a large number of genes implicated in atherosclerosis is especially valuable, because it provides clues to pathological processes that can now be investigated in HGPS patients or animal models. Keywords: microarrays, Hutchinson\u2013Gilford progeria syndrome, HGPS'",[15268757],['Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis.'],['2004 Aug'],"[['Csoka AB', 'English SB', 'Simkevich CP', 'Ginzinger DG', 'Butte AJ', 'Schatten GP', 'Rothman FG', 'Sedivy JM']]","['GPL97', 'GPL96']","['[HG-U133B] Affymetrix Human Genome U133B Array', '[HG-U133A] Affymetrix Human Genome U133A Array']","['GSM87751', 'GSM88309', 'GSM88289', 'GSM88312', 'GSM88292', 'GSM88301', 'GSM88295', 'GSM88298', 'GSM88315', 'GSM88304', 'GSM88287', 'GSM88284', 'GSM88307', 'GSM88296', 'GSM88310', 'GSM88290', 'GSM88313', 'GSM88293', 'GSM88282', 'GSM88299', 'GSM88302', 'GSM88305', 'GSM88308', 'GSM88285', 'GSM88288', 'GSM88311', 'GSM88314', 'GSM88291', 'GSM87553', 'GSM88286', 'GSM88294', 'GSM88283', 'GSM88297', 'GSM88300', 'GSM88303', 'GSM88306']",['Homo sapiens'],['Expression profiling by array']
